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Abstract 
 
Study n. 1: Aujeszky Disease: serological and virological surveillance in Italy during 2012-2014 
Although wild boar can act as a persistent Aujeszky’s disease (AD) reservoir, limited data are 
available on long-term epidemiology in free-ranging wild boar living in areas where industrial 
swine herds are limited. Hence, this study provides crucial information, which fills this knowledge 
gap, on the natural dynamics of AD infection. From 3260 sera sampled during eight hunting 
seasons, 162 (4.97%) were tested positive. Factors, including the animal’s age class, and the 
sampling year, had significant effects on the probability of the wild boar being seropositive, while 
wild boar mean abundance per area, yearly abundance and the total number of pig farms, as well 
as interactions among age, year and sex, were not significant. In particular, a positive trend of 
seroprevalence was observed over the years, with values ranging from 2.1 to 10.8%. This long-
term surveillance showed an increase in seroprevalence with a higher probability of being 
seropositive in older individuals and the independence of wild boar seropositivity from the 
likelihood of contact with pigs in the area. 
 
Study n. 2: Genomic characterization of pseudorabies virus strains isolated from swine in Italy 
In this study, we undertook the genomic characterization of 44 pseudorabies virus (PRV) strains 
originated on pig farms isolated in Italy during 1984–2010. The characterization was based on 
partial sequencing of the UL44 (gC) and US8 (gE) genes. Thirty six porcine PRV strains, which were 
closely related to those isolated in Europe and America in the last 20 years belong to cluster B in 
both phylogenetic trees. Six porcine strains that do not belong to cluster B are related in both gE 
and gC phylogenetic trees to the ‘old’ porcine PRV strains isolated in the 1970s and 1980s. In the 
last two decades, the presence of these strains in domestic pig populations has been reduced 
drastically, whereas they are prevalent in wild boar. The two remaining strains have an interesting 
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genomic profile, characterized by the gC gene being closely related to the old porcine PRV strains, 
and the gE gene being similar to that of recently isolated strains. These results provide interesting 
insight into the genomic characterization of PRV strains and reveal a clear differentiation between 
the strains isolated from wild boar and those originating from domestic pigs. 
 
Study n. 3: Detection and molecular analysis of pseudorabies virus strains isolated from dogs 
and wild boar in Italy 
Aujeszky’s disease (AD) is one of the most economically important diseases of farmed pigs. Wild 
boars can act as reservoirs and might represent a potential threat for domestic animals, including 
dogs. The aim of this study was to report the results of an AD survey based on the Pseudorabies 
virus (PRV) genome detection in samples of dogs clinically suspected of AD and of wild boars 
collected during four consecutive hunting seasons in the period 2010–2014. Genomic 
characterization was based on the partial gC sequence of the Italian strains and the comparison 
with those from domestic pigs and European PRV strains circulating in wild boars. The Italian PRV 
strains were mainly distributed into three different clusters and revealed two interesting findings. 
First, there was a clear distinction between the viral strains that were isolated from dogs used for 
hunting and subsequently traced back to wild boars and the strains that were isolated from 
working dogs and subsequently found to be closely related to domestic pigs. Second, the Italian 
epidemiological situation was found to be different from those of European countries in that the 
Italian situation was characterized by the presence of both the typical Italian clades 1 and 2 and 
supported by new patterns of aa deletions/insertions. Italian clade 1 included strains from hunting 
dogs and two Italian wild boars, and Italian clade 2 grouped with recent strains from dogs that 
were unable to hunt and domestic pigs that were related to one old reference strain (S66) and not 
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included elsewhere. Molecular and phylogenetic analyses of PRV strains are therefore necessary 
to improve the understanding of the distribution of the PRV clusters and their evolution. 
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Historical Background 
Aujeszky’s disease (AD) or pseudorabies is a disease with a long history. In the nineteenth century, 
the disease was linked with central nervous disorders in cattle, dogs and cats, characterized by 
itching, rubbing, exhaustion and paralysis. At that time, pigs did not come into the picture. In the 
USA, the oldest descriptions of a disease that closely resembles Aujeszky’s disease was called 
“mad-itch” in cattle and was referred to in the agricultural magazines “Cultivator” (1839) and 
“New England Farmer” (1844) (Hanson, 1954). Similar reports were made later in Europe. In 1889, 
Strebel (1889) published his findings on four cows with itching in Switzerland (“Juckkrankheit”) 
and mentioned that he had seen five similar cases in the past in his region. The Hungarian 
veterinary surgeon Aladar Aujeszky was the first to demonstrate the infectious origin of the 
disease and to forward the idea that the disease was distinct from rabies (Aujeszky , 1902). 
 
Figure n. 1: Aujeszky Aladar 
 He could induce nervous symptoms and death in rabbits within a period of 48 h with tissue 
suspensions from an ox with the following clinical picture: excitation and nasal pruritus, followed 
by convulsions and death within half a day. He was successful in repeating his experiment with 
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brain material from a cat and a dog which died quickly after showing similar symptoms. Aujeszky 
was convinced that he dealt with a virus that was different from rabies virus based on some 
specific observations, such as short time of incubation, quick course of disease and infectivity of 
blood. Afterwards, Schmiedhofer (1910) , Shope  (1931 and 1934) and Elford and Galloway (1936) 
brought the necessary proofs to demonstrate that a virus with a size between 100–150 nm was 
the cause of the disease based on ultrafiltration experiments. Reagan et al. were the first to 
visualize the virus (1952). Based on immunological studies, virus morphology, intranuclear 
inclusions and ether sensitivity, Sabin (1934) and Kaplan and Vatter (1959) classified Aujeszky’s 
disease virus (ADV)/pseudorabies virus (PRV) in the herpesvirus group. PRV was linked with 
sporadic problems in pigs world-wide and pigs were identified as a reservoir between 1920 and 
1940 (Kohler and Kohler , 2003). During the intensification of pig breeding in the nineteen-fifties, 
nineteen-sixties and nineteen-seventies, increasing incidences of severe clinical outbreaks were 
reported in swine. Several pig specialists are convinced that an increase in virulence occurred 
during this period, however a cell biological and molecular explanation is lacking. 
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Aetiology 
Classification and nomenclature 
PrV belongs to the family of the Herpesviridae, subfamily Alphaherpesvirinae, genus Varicellovirus. 
The general structure of a pseudorabies virion is given in Figure n.2.  
 
Figure n. 2: Structure of a pseudorabies virion 
The virion consists of a double stranded DNA genome of approximately 150 kbp, surrounded by a 
capsid, tegument and envelope. The genome of PRV belongs to the class D genomes of the 
herpesviruses. It consists of two unique regions, a long one (unique long, UL) and a short one 
(unique short, US) flanked by two repeat sequences, an internal one (IRS) and a terminal one (TRS) 
[4]. The whole genome has been sequenced and published by Klupp et al. (2004). The different 
genes within the genome of the alphaherpesviruses are designated by a two letter code UL or US 
depending on its position in the unique long (UL) or unique short (US), followed by a number. The 
number gives the place of the gene within each specific region. The capsid of alphaherpesviruses 
encloses and protects the large genome. It consists of 162 capsomers, 150 hexons (one hexon 
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consists of 6 molecules VP5 (protein expressed by UL19 (pUL19)) and 6 molecules VP26 (p(UL35)) 
and 12 pentons (11 pentons consist of 5 molecules of VP5 (p(UL19)); 1 penton consists of 12 
molecules of p(UL6) and forms the cylindric entry pore for newly produced dsDNA), both linked by 
triplexes (one molecule of VP19C (p(UL38)) and two molecules of VP23 (p(UL18)), all nicely 
arranged in an icosahedral lattice (Newcomb et al., 1999) (Figure n.3).  
 
Figure n. 3: Structure of the PRV virion. PRV virions are composed of four structural elements. The 
double-stranded DNA genome is housed in an icosahedral capsid. The tegument is a collection of 
approximately 12 proteins organized into at least two layers, one which interacts with envelope 
proteins and one that is closely associated with the capsid. The envelope is a lipid bilayer infused 
with transmembrane proteins, many of which are modified by glycosylation. Listed are proteins 
thought to be components of the virion; however, not all proteins are represented in the cartoon.  
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The space between the capsid and the envelope is filled with tegument proteins, which comprise 
besides viral proteins cellular actin. Tegument proteins are important during entry, priming the 
cell for virus replication, primary envelopment at the inner nuclear membrane and secondary 
envelopment at trans-Golgi vesicles (Mettenleiter., 2006). The envelope is a bilayered 
phospholipid membrane which is pinched off from the cell membrane during assembly at trans-
Golgi vesicles. It contains 10 glycoproteins (gB, gC, gD, gE, gH, gI, gK, gL, gM, gN) with gB forming 
homodimers, gE/gI, gH/gL and gM/gN forming hetero oligomers (Mettenleiter., 2000) and at least 
2 nonglycosylated proteins (p(UL43), p(US9)) (Brideau et al., 1998; Klupp et al., 2005). The 
envelope proteins play important roles in binding, internalization, envelopment, egress, cell-
associated spread, induction of protective immunity and immune evasion. Different domains in 
both the extra- and intra-envelope regions are important for these functions (Figure n.4). 
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Figure n. 4: Linear map of the PRV genome: predicted gene and transcript organization. The PRV 
genome consists of a long and a short unique segment, named UL and US, respectively. The US 
region is flanked by the inverted repeats IRS and TRS. The predicted locations of core and 
accessory genes, transcripts, DNA repeats, splice sites, and the origin of replication are indicated.  
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Virus-cell interactions 
An overview of the PRV replication is given in Figure n.5.  
 
Figure n. 5: Replication cycle of PRV. 1. Entry begins with attachment or binding of the virus 
particle to the cell surface. In PRV, this initial binding step is an interaction between gC in the 
virion envelope and heparan sulfate on the surface of the cell. 2. The next steps of entry require 
gD, gB, gH, and gL. In PRV, although gD is not essential for membrane fusion or cell-cell spread, gD 
interacts with the cellular herpesvirus entry mediator (HVEM) and is required for entry of 
extracellular virus (penetration). 3. After fusion of the virion envelope with the cell membrane, the 
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capsid and tegument proteins are released into the cell. The viral tegument proteins begin 
takeover of the host cell protein synthesis machinery immediately after entering the cell. 4. The 
capsid and tightly bound inner tegument proteins are transported along microtubules to the cell 
nucleus. 5. The VP16 tegument protein localizes to the nucleus independent of the capsid and 
transactivates cellular RNA polymerase II transcription of the only immediate-early protein of PRV, 
the HSV ICP4 homolog IE180. 6. IE180 protein expressed in the cytoplasm is transported back to 
the nucleus. 7. There, it transactivates RNA polymerase II transcription of the early genes. 8. Early 
proteins fall into two main categories. The first category comprises 15 proteins involved in viral 
DNA synthesis. 9. Seven of these proteins (UL5, UL8, UL9/OBP, UL29/ssDNABP, UL30/DNA Pol, 
UL42/Pap, and UL52) (shown in blue) are essential for replication of the viral DNA. DNA replication 
occurs by a rolling-circle mechanism. 10. The second category comprises three proteins thought to 
act as transactivators of transcription (EP0, US1, and UL54). 11. Onset of DNA synthesis signals the 
start of the late stage of the PRV replication cycle and synthesis of true late proteins. 12. The 
capsid proteins are transported to the nucleus, where they assemble around a scaffold composed 
of the product of the UL26 and UL26.5 genes. 13. The mature capsid is composed of five proteins 
(UL19/VP5, UL18/VP23, UL25, UL38, and UL35). The product of the UL6 gene acts as a portal for 
insertion of the genomic DNA into the capsid. UL32, UL33, UL15 (Ex2), and UL17 are all involved in 
cleavage and packaging of the viral DNA. 14. During primary envelopment, the fully assembled 
nucleocapsid buds out of the nucleus, temporarily entering the perinuclear space. This process 
involves the products of the UL31 and UL34 genes along with the US3 kinase. 15 and 16. The 
nucleocapsid (15) loses its primary envelope and (16) gains its final envelope by associating with 
tegument and envelope proteins and budding into the trans-Golgi apparatus. 17. The mature virus 
is brought to the cell surface within a sorting compartment/vesicle derived from the envelopment 
compartment. 
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PRV has developed an ingenious complex system to enter a host cell. It consists of a cascade of 
interactions between viral and cellular components. The attachment is initiated by an unstable 
binding mediated by the viral envelope glycoprotein gC and cellular heparin sulfate proteoglycans 
exposed at the plasma membrane (Mettenleiter et al., 1990). Next, PRV is firmly bound to the cell 
by glycoprotein gD which is interacting with at least one of three cellular receptors: nectin 1, 
nectin 2 and CD55 (Mettenleiter., 2002; Spear et al., 2000). The presence of different receptors for 
gD may explain the extreme pantropic character of PRV and the possibility to infect non-porcine 
mammals. Binding is followed by fusion coordinated by gB, gD and gH/gL which all probably find 
their own not yet identified cellular counterparts (Klupp et al., 1997; Rauh et al., 1991). Next, 
capsids of alphaherpesviruses are transported to the nucleus via microtubules (Smith et al., 2002). 
Upon arrival in the nucleus, the PRV genome is transcribed in a cascade-like fashion (Ben-Porat et 
al., 1985). First, immediate-early (IE) genes are transcribed during the first 2 h after nucleus entry. 
For this transcription the host nuclear machinery is used. IE180 is the only PRV IE protein. It is 
activating not only promoters of PRV genes (US4(gG), UL12 (deoxyribonuclease), UL22 (gH), UL23 
(thymidine kinase) and UL41 (viral host shut off)) but also promoters of cellular genes and genes of 
other viruses (cross-activation) (Chang et al., 2004; Ou et al., 2002; Taharaguchi et al., 1994; Wong 
et al., 1997; Wu et al., 1988). Early (E) genes are the next group of genes that are active. Like 
IE180, several of them (EP0, UL54 and UL48) are regulating the expression of genes of PRV and the 
cell (Fuchs et al., 2002a; Ono et al., 1998; Schwartz et al., 2006). Other E genes are producing 
proteins which are important for nucleotide synthesis (UL23, UL39/UL40, UL50) and DNA 
replication (UL5, UL8, UL9, UL29, UL30, UL42, UL52). The UL23-encoded thymidine kinase is 
phosphorylating deoxythymidine into deoxythymidine-triphosphate, one of the four building 
stones of DNA. This non-essential enzyme in cell cultures is important for the replication of PRV in 
differentiated cells such as neurons in vivo (Kit et al., 1987). UL39 and UL40 products are forming a 
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viral ribonucleotide reductase, which reduces ribonucleotides into deoxyribonucleotides (Kaliman 
et al., 1994) . The absence of this enzyme strongly attenuates the virus for replication in pigs (De 
Wind et al., 1993). The UL50 encodes a dUTPase which is cleaving dUTP into dUMP and 
pyrophosphate. dUMP may be enzymatically changed into dTMP and subsequently into dTTP. 
Deletion of UL50 results in a reduced virus replication in pigs (Jons et al., 1997). In analogy with 
herpes simplex virus, the proteins encoded by UL5, UL8 and UL52 are predicted to form a 
heterotrimeric primase-helicase complex, which together with p (UL9), is believed to recognize the 
site of initiation of DNA synthesis and unwinds the supercoiled DNA (Lehman et al., 1999). 
Products of UL30 and UL42 form the DNA-dependent DNA polymerase which uses the rolling-
circle mechanism to produce a long head-to-tail concatemeric DNA strand (Berthomme et al., 
1995). The precise mechanism is still not completely understood, and still controversially 
discussed. Finally late (L) genes become expressed. They mainly encode structural proteins, such 
as capsid and tegument proteins and envelope (glyco)proteins. All capsid proteins enter the 
nucleus for the formation of the capsids. Scaffolding proteins encoded by UL26 and UL26.5 aid in 
the construction of the capsids. The concatemeric DNA is cleaved into monomeric forms and 
simultaneously pulled into newly formed capsids through the cylindric entry pore encoded by UL6 
(special penton of the capsid). The nucleocapsid is then ready for the primary envelopment at the 
inner nuclear membrane and subsequent de envelopment at the outer nuclear membrane. At 
least three viral proteins encoded by US3, UL34 and UL31 have been put forward to be crucial 
players in this process (Mettenleiter ., 2006). The following steps are proposed: p(UL31) is a 
tegument protein which takes care of the first positioning of the nucleocapsids at the inner 
membrane where p(UL34), a transmembrane protein, is anchored. By budding, primary enveloped 
particles are entering the lumen and by fusion the nucleocapsids are released in the cytoplasm 
(Fuchs et al., 2002b). Next, the nucleocapsids are transported to the trans-Golgi vesicles, the site 
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for the secondary envelopment process. The cytoskeletal structures and motor proteins necessary 
for the transport to this site are not characterized yet. It is very well possible that tegument 
proteins encoded by US3, UL36 and UL37 which are found on the outside of cytoplasmic 
nucleocapsids, are involved in this migration with p(UL36) physically interacting with p(UL37) 
(Fuchs et al., 2004; Klupp et al., 2002). The envelope glycoproteins are anchored in the 
membranes of TGN vesicles, presenting their cytoplasmic tails in the cytosol. On these tails, 
tegument proteins are assembled. P(UL11) and p(UL49) have already been localized at this site. 
The latter tegument protein interacts with the tails of gE and gM (Fuchs et al., 2002c). Finally, the 
virus is released by exocytosis. 
Virus-host interactions 
In the absence of specific immunity 
The virulence of PRV is determined by its capacity to replicate and to invade in the pig. The 
primary site of replication is situated in the nasal cavity, tonsils, pharynx and lungs (Sabo et al., 
1968; Sabo et al., 1969; Wittmann et al., 1980; Miry and Pensaert, 1989; Pol, 1990; Kritas et al., 
1994a; Kritas et al., 1994b). The extent of replication at the different localisations depends on the 
amount of virus in the inoculum and on the route of inoculation. After replication in the 
epithelium the virus spreads to the underlying connective tissue in a very short time. At 24 h PI, 
viral antigens are already found in the nasal cavity in groups of epithelial cells, fibrocytes and 
nerve cells. At 48 h PI, viral antigens are detected in larger plaques which are extended over 
epithelium and underlying connective tissue. including nerves and endothelial walls. These 
plaques of local virus replication undergo extensive necrosis. A similar ‘plaque-wise’ spread is also 
found in the tonsils and lungs. Virus can spread from the primary sites to distant secondary 
replication sites by lymph, blood and nerves. Both cell-free and cell-associated viremia are possible 
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(Nauwynck and Pensaert, 1995a). Virus replication at secondary sites such as draining lymph 
nodes, olfactory bulb. medulla, spleen, kidneys, ovaries and uterus starts at 48 h PI. It is less 
extensive than at the primary sites and is clearly reduced with the onset of the immune response 
starting from 7 days PI. Despite the presence of a humoral and cellular immunity, virus can be 
isolated from tonsils up to 18 days PI (Sabo et al., 1969) and from nasal swabs up to 13 days PI 
(Pensaert et al., 1990; Vannier et al., 1990). The role which different viral proteins play in this 
pathogenesis picture has been studied by different research groups by means of deletion mutants. 
Role of envelope glycoprotein gC 
Somewhat different data exist on the effect of the deletion of gC on virus replication and virulence 
in pigs. In neonatal pigs no effect was found while in 3-week old pigs virulence was reduced 
(Mettenleiter et al., 1989; Kritas et al., 1994a; Kritas et al., 1994b). In what way age influences the 
virulence is not clear at present. 
Role of envelope glycoprotein gD 
By the use of a phenotypically complemented gD mutant the role of gD in neuro-invasion of PRV 
became clear (Mulder et al., 1995). The loss of gD did not inhibit but only slowed down viral 
spread over the neuronal pathways up to the central nervous system. This proved that the trans-
synaptic spread of PRV in pigs may occur in a direct cell-associated way. 
Role of enuelope glycoprotein gE 
The viral glycoprotein gE forms a non-covalently linked complex with g1, which becomes 
expressed in the cell membrane of the infected cell and is present in the viral envelope. The 
absence of the entire gE glycoprotein or deletion of two amino acids (val-125 and cys-126) results 
in a reduction of virulence (Jacobs et al., 1993; Kritas et al., 1994a; Kritas et al., 1994b). After an 
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intranasal inoculation central nervous disorders, respiratory problems, anorexia and fever are 
absent and pigs do not succumb. This reduction in virulence reflects well the impaired capacity to 
invade, which can be found at different neuronal levels. Although an infection with the gE- mutant 
gives a similar number of foci of infection in the epithelium of the nasal mucosa early after 
infection (48 h PI) in comparison with its parental strain. the plaque-wise spread into the 
underlying connective tissue was clearly affected. The reason for this can be found in the less 
efficient release of the virus and the modulating role that gE plays in the direct cell-to-cell spread. 
The Ka gE- mutant also demonstrates a reduced invasion and spread into the central nervous 
system. This has been demonstrated for both the olfactory and trigeminal pathway. A much lower 
number of infected neurons was detected on the first neuronal level and almost no infection was 
found in more distant levels in the central nervous system. The lower capacity to invade into the 
nervous tissues is probably an accumulation of different effects such as (i) the smaller plaques 
formed in the nasal mucosa causing a lower number of neuronal extensions which are reached 
and a lower number of neurons which become infected, (ii) the deficient virus release, (iii) the 
affected cell-to-cell spread at the site of the synapses and (iv) an impaired anterograde transport, 
as demonstrated in the trigeminal pathway (Kritas et al., 1995). Furthermore, it has been shown 
that virus titers in internal organs such as liver, kidneys, adrenal glands and spleen of gE-negative 
PRV infected pigs are much lower than those obtained with the parental strain. In conclusion, we 
can state that gE forms an important invasion and virulence determinant. 
Role qf envelope glycoprotein gl 
PRV without gI is able to replicate in the nasal mucosa to the same extent as the parental strain 
does (Kritas et al., 1994a,b). Although this mutant can invade in the central nervous system along 
neurons, the total number of infected neurons is clearly reduced in both the trigeminal and 
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olfactory pathways. Parallel with its replication pattern, the g1 mutant has an intermediate 
position concerning its virulence in pigs between the parental strain and the gE mutant. This 
information indicates that although gE/gI forms a complex, this conformation is not essential for 
all functions. The viral glycoprotein gE is able to perform some of the functions in the absence of 
g1. 
Role of other viral proteins 
Deletion of the gene coding for gG or 28 K, two proteins of which the function has not been 
identified so far, does not affect the virulence indicating the minor roles these proteins play in the 
replication in pigs (Kimman et al., 1992). The US3 mutant which does not express the protein 
kinase PK (US31 demonstrated a reduced virulence in pigs (Kimman, 1994a; Kimman, 1994b). PK 
(US3) has been shown to have an in vitro phosphorylation capacity of a major virion 
phosphoprotein of 112 kDa (Zhang et al., 1990). Although the function of the formed 
phosphoprotein is unknown, it is necessary for an efficient replication in vitro. The reduced 
capacity to replicate may explain its reduced virulence. No data are available at present, on the 
effect of a deletion of the gene encoding another protein kinase PK (UL13). The role of two viral 
enzymes involved in nucleic acid metabolism, thymidine kinase (TK) and ribonucleotide reductase 
(RR) has already been clarified. Ribonucleotide reductase reduces the ribonucleotidediphosphates 
to desoxy-products which can be used for DNA synthesis. Thymidine kinase is necessary for the 
phosphorylation of deoxythymidine to its monophosphate product. As both enzymes are present 
in dividing cells but not in non-dividing cells such as neurons it is easy to understand that TK and 
RR mutants have a reduced virulence to pigs (Kit et al., 1985: de Wind et al., 1993). 
In the presence of specific immunity 
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The degree with which replication of PRV may be restricted in pigs depends on the immunisation 
approach. Although a total inhibition is found in the nasal cavity and pharynx in pigs which are 
reinfected 1 and 2 months after the primary infection, viral antigens can already be detected in a 
small number of free alveolar cells and alveoli in the lungs (Miry and Pensaert, 1989). From these 
findings it was hypothesized that alveolar macrophages first become infected which transmit the 
virus afterwards to alveolar epithelium and underlying connective tissue via a direct cell-to-cell 
contact. In pigs immune after vaccination the protection is less efficient as viral antigens were not 
only present in the deeper airways but also in the pharynx, tonsils and nasal cavity (Miry and 
Pensaert, 1989; Wittmann et al., 1980). The viral antigen positive cells were located in clusters 
mainly in the epithelium. Despite the presence of a vaccination immunity a cell-associated viremia 
can still be found (Wittmann et al., 1980). This allows PRV to reach inner organs. When an infected 
leucocyte sticks in the microcirculation, PRV may spread to the contacting cells in a plaque-wise 
manner. The formation of a single plaque will not result in signs except in the uterine circulation. 
Once PRV reaches the fetal tissues the infection will spread over the uterus contents till abortion 
occurs (Nauwynck and Pensaert, 1992). In recent experiments of the author, the role of 
glycoproteins which become expressed outside the carrier blood mononuclear cell in adhesion to 
endothelial cells and further spread through the maternal placenta has been elucidated. The 
adhesion of the infected blood mononuclear cells to the capillary wall was mediated by a 
physiological process and not by the expressed viral glycoproteins. The latter seems logical as 
antibodies directed against them completely inhibit cell adhesion (Hanssens et al.. 1993). After 
adhesion PRV is able to spread through the maternal placenta which consists of endothelial cells, 
fibrocytes and uterine epithelial cells in a direct cell-associated way as shown by the use of a gD-
deletion mutant. After injection of gD- PRV infected mononuclear cells in the uterine artery gD- 
PRV spreads through the maternal placenta in order to infect fetal tissue. gD- PRV was 
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demonstrated in the fetuses 2 weeks after inoculation. From the different pathogenetic studies it 
can be concluded that the cell-associated spread of PRV enables the virus to evade immunity in 
vaccinated pigs. 
Immunogenicity of PRV glycoproteins 
In the course of the present thesis, it became clear that the different envelope glycoproteins are 
responsible for important interactions of PRV with host cells. Thus, it is not surprising that the 
immunity induced against these specific viral proteins is very effective in the protection of the pig, 
not only clinically but also virologically. The specific immunity against the envelope glycoproteins 
consists of two components: antibodies and cytotoxic T-lymphocytes. Antibodies can act by 
themselves (direct way) or mediate some antiviral activities with the help of complement and 
leucocytes (indirect way). Direct effects are obtained by blocking the glycoprotein site which is 
active during virus entry, cell adhesion and cell fusion. So has been found that some monoclonal 
and polyclonal antibodies directed against gB, gC and gD neutralize PRV in the absence of 
complement (Wathen et al., 1985; Ben-Porat et al., 1986; Eloit et al., 1990; Marchioli et al., 1988; 
Coe and Mengeling, 1990) that monospecific antisera against gB and gC inhibit the adhesion of 
infected cells in suspension (Hanssens et al., 1993) and that monoclonal antibodies against gB, gD 
and gE reduce the plaque size in infected monolayers (Nauwynck and Pensaert, 1995b). Indirect 
effects are possible not only with the previously mentioned antibodies but also with antibodies 
bound to functionally inactive regions of the envelope glycoproteins. The bound antibodies may 
activate complement, causing damage of the membrane in which the envelope glycoproteins are 
anchored. This may lead to cell death and virus inactivation. This is the reason why non-
neutralizing monoclonal antibodies against gB, gC, gD and gE may cause inactivation of the virus in 
the presence of complement (Wathen et al., 1985; Fuchs et al., 1990; Nakamura et al., 1990). 
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Antibodies attached to the expressed viral glycoproteins may also cause cell death after 
interaction with Fc receptors on phagocytes (ADCC by monocyte/macrophages and neutrophils). 
Porcine polyclonal antisera against gC show a high ADCC-activity in the presence of 
polymorphonuclear cells, whereas antisera against gB and gD had minimal ADCC-activities (Iglesias 
et al., 1990). Although antibodies against other viral proteins such as gG, the IEP 180 and 
nucleocapsid proteins do exist, they are immunologically of no importance. The reason for this is 
that these proteins are active only inside the infected cell where they cannot be reached by 
antibodies. Cytotoxic T-lymphocytes directed against gC in combination with MHCI are effective in 
eliminating infected cells (Zuckerman et al., 1990). 
Virus-respiratory tract interactions 
The general pathogenesis picture of PRV infections in pigs can be summarized as follows. The virus 
primarily replicates in the respiratory tract, especially the upper respiratory tract, spreads along 
cranial nerves to the brains and via lymph and blood to internal organs, with the reproductive 
organs being important targets. Replication in the respiratory tract, central nervous system and 
reproductive organs is responsible for pathological changes causing respiratory, nervous and 
reproductive disorders. Clear changes in virus-host interactions have been reported over time 
which point to differences in virulence of the virus. The original reports of Aujeskzy’s disease were 
only describing nervous disorders, mainly in cattle and dogs and rarely in pigs. The involvement of 
the respiratory tract in the pathogenesis was not at all clear at that moment. Shope (1934) was the 
first one to demonstrate that PRV was present in nasal secretions of pigs for several days after 
intranasal infection and Mc Ferran and Dow (1964) showed that PRV was shed from 1 to 9 days 
after inoculation in the nasal secretions and up to 17 days intermittently. Researchers of the 
Veterinary Research Laboratories (Stormont, Belfast, Northern Ireland) discovered clear 
27 
 
pathogenetic changes between strains which were isolated in their region over time. The Northern 
Ireland PRV strain 1 (NIA-1) originally isolated in the nineteen-sixties was found to replicate in the 
nasal and pharyngeal mucosa starting from 24 h post inoculation. During the replication of at least 
one week, no respiratory disease and gross pathological lesions were found in the respiratory 
tract. After 48 h, virus was detected in the central nervous system where it was spreading over 
time. The dissemination via lymph and blood and replication in internal organs was very restricted. 
The pathogenesis of infections with NIA-2, which was isolated one decade later, behaved 
somewhat similar. The more pronounced respiratory lesions (rhinitis and pneumonia) were 
attributed to the way of inoculation (Baskerville, 1971). The virus was administered via aerosol, 
which allows the virus to reach deeper parts of the respiratory tract than when the virus is instilled 
intranasally. NIA-3 was isolated in the early nineteen-seventies during a severe outbreak, with 
100% mortality in piglets during their first weeks of age. Several sows aborted. The extremely high 
mortality in piglets and abortions were new findings at that time. This strain was highly virulent for 
the respiratory tract. As soon as 30 h after intranasal inoculation, pyrexia was measured and 48 h 
post inoculation, severe depression, tremors of the extremities and sneezing with a mucopurulent 
nasal discharge were noticed (Pol et al., 1989). Pathologically, the nasal and pharyngeal mucosae 
were hyperemic at 24 h post inoculation and necrotic starting from 48 h post inoculation. This 
extremely aggressive form of Aujeszky’s disease was not reported before. Virologically, the virus 
had spread within 24 h through the basement membrane and was already replicating in several 
fibrocytes in the lamina propria. At 48 h post inoculation, the epithelial cells were sloughed away 
and large parts of the underlying connective tissue were necrotic. In the nineteen-sixties-
seventies, an increase in the invasive character of PRV at the level of the respiratory tract allowing 
the virus to find access to more nerves and to increase the viremia and to replicate to high levels 
in internal organs, including reproductive organs, was also reported in other countries. In Belgium, 
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a virulence switch has been recognized in the beginning of the nineteen-seventies (Pensaert et al., 
1987). A strain isolated in 1971 (NS374) from a few piglets with central nervous disorders but 
without a high mortality, respiratory problems and reproductive problems on the farm of origin, 
was inoculated in piglets of 7 weeks of age. A restricted replication was found in the respiratory 
tract. A viremia was not detected and in the central nervous system the virus could only be 
demonstrated in the brainstem. Besides fever, other clinical signs were not observed. In contrast, 
the 75V19 strain, which was isolated during a severe PRV outbreak with respiratory, nervous and 
reproductive problems in 1975, was replicating to higher titers in the respiratory tract compared 
to the NS374, gave a clear viremia and was replicating in different regions of the central nervous 
system. Similar observations of increased virulence were done in other West European countries 
(Akkermans et al., 1980; Pittler, 1982; Toma et al., 1985). The basis for the increased virulence is 
not known. Interesting are the observations made by Bitsch (1980) in Denmark. A link was made 
between the characteristics in vitro and the behavior in the field. The more invasive strains 
demonstrated a better cell-associated spread (larger syncytia). A similar finding was done with 
Belgian strains (Nauwynck, 1993). Over time, the cell-associated spread of PRV isolates seems to 
have improved. In one way or another there seems to be an advantage in evolution for PRV to 
spread in a cell-associated way. The replication kinetics and characteristics of PRV in the 
respiratory tract are influenced by different factors, such as virus strain as illustrated above, 
inoculation route, virus titer in the inoculum, animal age and genetics and immune status. In naïve 
pigs, PRV replicates first in the respiratory tract, mainly in the upper part, consisting of the nasal 
cavity, tonsils and the oropharynx upon intranasal/peroral inoculation. It infects primarily the 
epithelial cells and within 24 h it crosses the basement membrane in order to infect all cell types in 
the underlying tissues in a plaque-wise fashion (fibrocytes, endothelial cells, mononuclear cells) 
(Kritas et al., 1994a; Kritas et al., 1994b; Miry and Pensaert, 1989; Sabo et al., 1968; Sabo et al., 
29 
 
1969; Wittmann et al., 1980). How the virus penetrates easily through the mucus layer barrier on 
top of the epithelial cells and crosses the basement membrane barrier is not known and deserves 
more in depth studies. Replication in lower parts of the respiratory tract is restricted, except when 
virus is directly deposited in these locations, such as by intratracheal or aerosol inoculation 
(Baskerville, 1971; Miry and Pensaert, 1989). In the lungs, the virus replicates in all epithelial cell 
types and spreads plaque-wise without restrictions (Miry and Pensaert, 1989). Lung macrophages 
have also been identified as target cells (Iglesias et al., 1989). Between 2 and 5 days post 
inoculation, virus spreads in a cell-associated way over the whole mucosa and deep into the 
submucosa. Virus replication induces an enormous influx of phagocytes which as a first line 
defense start to attack the infected regions. The resulting massive destruction causes respiratory 
signs, such as sneezing, coughing, nasal discharge and dyspnea. During this invasion period, virus 
becomes transported over neurons, in blood and lymphatics and reaches important target organs 
such as the brain, lymphoid organs and pregnant uterus. Interferon-alpha is present starting from 
2 till 7 days post inoculation and the concentration is inversely proportional to the intranasal virus 
replication (Nauwynck and Pensaert, 1995a). The latter shows the importance of interferon-alpha 
in the control of virus replication in the nose and pharynx. Using nasal mucosal explants, Pol et al. 
(1991) demonstrated that interferon-alpha is diminishing the spread of PRV in the connective 
tissue but not in the epithelial cells. The reason why epithelial cells are not protected is not 
understood and should be further analyzed. With the appearance of a general and local humoral 
and cellular immunity starting from 6–7 days post inoculation, virus becomes neutralized and 
inactivated and infected cells are lysed and cleared by phagocytes (Kimman, 1994a). With the 
onset of the specific immunity, the recovery phase starts. Despite the presence of these different 
arms of the immune system, virus is completely eliminated only after 13 days post inoculation in 
the nasal cavity and 18 days post inoculation from the tonsils (Pensaert et al., 1990; Vannier et al., 
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1991). The ability to replicate at a low level in the presence of a specific immunity is indicative for 
the fact that PRV is able to overcome some antiviral actions of the immunity. This also forms the 
basis for replication of PRV in the respiratory tract of immune animals after previous infection or 
vaccination or after uptake of colostrum with anti-PRV antibodies. A reduced number of small foci 
of virus replication are still present in the respiratory tract, virus may still reach the trigeminal 
ganglion and virus may still be spread via infected monocytes in the blood. During the latter cell-
associated viremia virus may still cross the placenta and infect fetuses (Nauwynck and Pensaert, 
1992). The stronger the immune response and the more components of the immunity are 
activated, the better the protection. By using mutants, it is possible to study the role of certain 
non-essential viral envelope glycoproteins and viral enzymes in the replication and invasion 
capacities. PRV gC and gI negative mutants behaved like the wild type virus with respect to the 
number and size of the foci of infected cells in the mucosa/submucosa. In contrast, the absence of 
gE and gD resulted in a reduced number of infected cells and gave foci with smaller dimensions 
(Kritas et al., 1994a; Kritas et al., 1994b; Mulder et al., 1996). Concerning the enzymes, it was 
demonstrated that the absence of viral ribonucleotide reductase, dUTPase and US3-encoded 
protein kinase was reducing virus excretion in pigs, indicating that the replication was clearly 
affected (De Wind et al., 1993; Jons et al., 1997; Kimman et al., 1992). At what level these proteins 
are involved in the invasion of PRV through the different layers of the respiratory mucosa and 
submucosa is not known and merits further examination. 
Vaccination and control 
In order to guarantee a free trade of pigs in Europe, efforts have been made to eradicate PRV 
(Pensaert et al., 2004). In the past, PRV hindered free trade between countries such as Great 
Britain and several Scandinavian countries which were already free for decades by mainly a 
31 
 
stamping out policy and countries which were not free and wanted to export pigs to PRV free 
countries. Therefore, several exporting countries started programs to reach a PRV free status. For 
reaching this high sanitary status, huge efforts were necessary, especially in densely populated pig 
regions where the seroprevalence was high. In most of these regions a combination of vaccination 
during several years, which reduced virus circulation and seroprevalence, and culling at a moment 
of low seroprevalence was used, generally with success. This whole strategy was only possible 
with marker vaccines and a discriminating ELISA which is able to identify infected animals in a 
group of vaccinated animals (Van Oirschot et al., 1996). For PRV, the choice fell on a gE deletion 
vaccine, based on several molecular features. Deleting gE is attenuating PRV by reducing the cell-
associated transmission and neurological spread but does not hinder mass production in cell 
cultures and does not show a reduced induction of a protective immunity. Because latent virus 
may be reactivated and cause a new explosion of transmissions, it was generally feared that 
eradication programs would have met a lot of problems to be successful. This fear seemed to be 
unfounded in the field. At present, several countries are officially PRV free. Since PRV is still 
present in wild boars and feral swine in most of these countries, authorities should follow up the 
situation within this population and estimate the risk from this reservoir in the wild. 
Epidemiology 
Pseudorabies outbreaks occur in swine populations worldwide, resulting in substantial economic 
losses for affected countries. Many countries, such as Germany and the Netherlands, mounted 
successful agricultural campaigns to eradicate PRV from their swine populations. In 2001, 
Germany was listed as Aujeszky’s disease-free. Eradication efforts included selective culling of 
PRV-positive herds, widespread vaccination programs with marker viruses such as gE-null vaccine 
strains, restricted importation of swine, and improved herd management practices to isolate 
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swine from potential reservoirs of infection such as wild boar (Muller et al., 2003; Stegeman et al., 
1997; van Oirschot et al., 1986). In 2003, countries with documented cases of PRV (in alphabetical 
order) included Belarus, Brazil, Cuba, France, Hungary, Italy, Mexico, Panama, Poland, Portugal, 
Romania, Russia, Slovakia, Slovenia, Taiwan, and Ukraine. Pseudorabies outbreaks in Mexico are 
particularly troubling to U.S. state and federal agricultural officials, given Mexico’s border with the 
United States. This underscores the importance of surveillance and monitoring of movement of 
animals across U.S. borders. Information regarding global pseudorabies outbreaks was provided by 
the World Organization for Animal Health/Office International des Epizooties (web site address: 
www.oie.int). 
Clinical signs and pathogenesis 
Acute PRV infection of swine 
Outbreaks of PRV increased substantially coinciding with a dramatic increase in the intensity of 
swine production and close-quarter confinement of large numbers of pigs in swine barns. The 
increased stresses imposed on the swine coupled with closer contact provided ideal conditions for 
spread of PRV (Kluge et al., 1999). Primary viral replication occurs in the nasal and oropharyngeal 
mucosa (Masic et al., 1965). PRV is tropic for both respiratory and nervous system tissue of swine 
and viral particles enter sensory nerve endings innervating the infected mucosal epithelium. 
Morbidity and mortality associated with PRV infection varies with the age of the pig, overall health 
status of the animal, viral strain, and infectious dose. Younger swine are the most severely 
affected by PRV infection and typically exhibit symptoms of central nervous infection whereas 
older swine exhibit symptoms of respiratory disease (Kluge et al., 1999). For suckling piglets, the 
incubation period of PRV is typically 2 to 4 days. Initially, piglets are listless, febrile, and 
uninterested in nursing. Within 24 h of exhibiting these symptoms, the piglets will progressively 
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develop signs of central nervous system infection including trembling, excessive salivation, 
incoordination, ataxia, and seizures. Infected piglets may sit on their haunches in a “dog-like” 
position because of hind limb paralysis, lay recumbent and paddle, or walk in circles. Once piglets 
develop central nervous system abnormalities, they die within 24 to 36 h. Mortality of suckling 
pigs with pseudorabies is extremely high, approaching 100%. The cause of death in piglets has 
historically been attributed to viral encephalitis. However, recent work suggests that a peripheral 
host immune response to viral infection may be a significant determining factor in the death of 
infected animals (Brittle et al., 2004). Weaned pigs, ages 3 to 9 weeks of age, tend to develop 
symptoms highly reminiscent of those described for suckling pigs. However, the mortality rate is 
much lower. Typically, 50% of infected 3- to 4-week-old animals die. Pigs 5 to 10 weeks of age 
become listless and anorectic, and exhibit temperatures of 41 to 42°C within 3 to 6 days of 
infection. Animals often develop respiratory signs such as sneezing, nasal discharge, a severe 
cough, and difficulty breathing. Pigs with respiratory illness often lose significant body weight, a 
condition that translates directly into economic loss for swine producers. Signs of infection 
typically resolve after 5 to 10 days, with most pigs making a rapid recovery upon resolution of the 
fever and anorexia. If carefully nursed through their illness and treated for secondary bacterial 
infections when necessary, mortality rarely exceeds 10% (Kluge et al., 1999). In adult swine, 
respiratory signs are the hallmark of PRV infection although, sporadically, adult animals may 
exhibit central nervous system abnormalities varying from mild muscle tremors to violent 
convulsions. Although morbidity is quite high (approaching 100% of infected animals), mortality is 
relatively low (1 to 2% of infected animals). Typically, clinical signs appear in 3 to 6 days. 
Symptoms include a febrile response (41 to 42°C), listless behavior, lack of interest in eating, and 
mild to severe respiratory signs. These animals will typically exhibit rhinitis evidenced by sneezing 
and nasal discharge. The respiratory illness may progress to pneumonia with a harsh cough and 
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labored breathing. Sick animals will become emaciated and lose considerable body weight, 
resulting in financial losses for swine producers. The duration of clinical illness is 6 to 10 days, and 
infected animals typically recover rapidly (Kluge et al., 1999). Pregnant animals infected with PRV 
in the first trimester of pregnancy will usually reabsorb the fetuses in utero. If infection occurs 
within the second and third trimester of pregnancy, infection typically results in abortion, 
stillbirths, or weak piglets that die within 48 h of birth. PRV-induced infertility results from the 
virus crossing the placenta and infecting animals in utero. In fact, in a given litter, some pigs may 
be born normal, while others are weak and some are stillborn due to transplacental transmission 
of virus. Reproductive failure usually has a low incidence on an infected farm, occurring in 20% or 
less of pregnant animals (Kluge et al., 1999). 
PRV latency in swine 
During an acute infection, viral particles replicate in the oropharyngeal mucosa then enter sensory 
nerve endings innervating the site of infection. Retrograde transport of virus particles occurs in the 
maxillary branch of the trigeminal nerve (cranial nerve V), the glossopharyngeal nerve (cranial 
nerve IX), and the olfactory nerve (cranial nerve I) (Maes et al., 1997). The term latent infection of 
swine is used to describe a long-term infection in which the PRV genome is quiescent and PRV 
virions cannot be recovered. The predominant sites of PRV latency are the trigeminal ganglia 
(originally described as gasserian ganglia) and the sacral ganglia in feral swine. Similarly, the 
predominant sites of latent neuronal infection of the human alphaherpesviruses HSV-1 and HSV-2 
are the trigeminal ganglia and the sacral ganglia (Whitley, 2001). Latent PRV genomes can be 
detected in the other neural tissues such as the olfactory bulb and brain stem (Rziha et al., 1986; 
Sabin, 1938; Sabo and Rajcani, 1976; Wheeler et al., 1991). Each latently infected cell body of the 
trigeminal ganglia harbors approximately 30 copies of the viral genome (Rziha et al., 1986). In 
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addition, tonsillar lymph nodes are reported sites of latency (Brittle et al., 2004; Brockmeier et al., 
1993; Cheung et al., 1994; Sabo and Rajcani, 1976). However, the rate of PRV DNA detection in 
tonsils is often lower than that seen in trigeminal ganglia, and questions remain as to whether 
tonsils constitute a true site of latency rather than the site of low but persistent infection (Maes et 
al., 1997). The cell type harboring PRV within the tonsillar tissue remains unknown. Reactivation 
and shedding of virus in latently infected animals frequently occurs after stressful experiences. 
Stressors include concomitant disease conditions, vehicular transport, poor animal husbandry, 
farrowing (i.e., giving birth to piglets), and treatment with immunosuppressive agents, e.g., 
corticosteroids (Davies and Beran, 1980; Rziha et al., 1989, Rziha et al., 1986, Thawley et al., 1984; 
van Oirschot and Gielkens, 1984; Wittmann et al., 1983). 
Lethality of pseudorabies infection in nonnative hosts 
In addition to infection of its natural swine host, PRV infects a broad range of vertebrates. These 
include cattle, sheep, dogs, cats, goats, chickens, raccoons, possums, skunks, rodents, rabbits, 
guinea pigs, and, rarely, horses (Field and Hill, 1974; Gustafson, 1986; Kimman et al., 1991; 
McCracken et al., 1973; Pensaert and Kluge, 1989; Wittmann et al., 1980). Infection of carnivores, 
such as bears and wild felines, has also been reported to occur after consumption of raw PRV-
infected meat (Capua et al., 1997; Glass et al., 1994; Zanin et al., 1997). Infection of nonnative 
hosts with a wild-type PRV strain is uniformly lethal. While PRV does not infect humans, 
experimental studies in nonhuman primates indicate that rhesus monkeys and marmosets are 
susceptible to infection. Other higher-order primates, such as chimpanzees, are not susceptible to 
infection (Enquist, 1999; Kluge et al., 1999). 
Lesions  
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Focal necrotic and encephalomyelitis lesions occur in the cerebrum, cerebellum, adrenals and 
other viscera such as lungs (Figure n. 6), liver or spleen. In fetuses or very young piglets, white 
spots on liver are pathognomonic of their infection by the virus (Figure n. 7). Intranuclear lesions 
are frequently found in several tissues. 
 
 
 
 
 
Figure n. 6: Focal necrotic lesions occur in the lungs 
 
Figure n. 7: White spots on liver are pathognomonic in fetuses or very young piglets  
Diagnosis 
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Identification of the agent 
Virus isolation 
The diagnosis of Aujeszky’s disease can be confirmed by isolating the virus from the oro-
pharyngeal fluid, nasal fluid (swabs) or tonsil swabs from living pigs, or from samples from dead 
pigs or following the presentation of clinical signs such as encephalitis in herbivores or carnivores. 
For post-mortem isolation of SHV-1, samples of brain, tonsil, and lung are the preferred 
specimens. In cattle, infection is usually characterized by a pruritus, in which case a sample of the 
corresponding section of the spinal cord may be required in order to isolate the virus. In latently 
infected pigs, the trigeminal ganglia is the most consistent site for virus isolation, although latent 
virus is usually non-infective unless reactivated, making it difficult to recover in culture. The 
samples are homogenized in normal saline or cell culture medium with antibiotics and the 
resulting suspension is clarified by low speed centrifugation at 900 g for 10 minutes. The 
supernatant fluid is used to inoculate any sensitive cell culture system. Numerous types of cell line 
or primary cell cultures are sensitive to SHV-1, but a porcine kidney cell line (PK-15) is generally 
employed. The overlay medium for the cultures should contain antibiotics (such as: 200 IU/ml 
penicillin; 100 μg/ml streptomycin; 100 μg/ml polymyxin; and 3 μg/ml fungizone). SHV-1 induces a 
cytopathic effect (CPE) (Figure n. 8) that usually appears within 24–72 hours, but cell cultures may 
be incubated for 5–6 days. The monolayer develops accumulations of birefringent cells, followed 
by complete detachment of the cell sheet. Syncytia also develop, the appearance and size of which 
are variable. In the absence of any obvious CPE, it is advisable to make one blind passage into 
further cultures. Additional evidence may be obtained by staining infected cover-slip cultures with 
haematoxylin and eosin to demonstrate the characteristic herpesviral acidophilic intranuclear 
inclusions with margination of the chromatin. The virus identity should be confirmed by 
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immunofluorescence, immunoperoxidase (Figure n. 9), or neutralisation using specific antiserum. 
The isolation of SHV-1 makes it possible to confirm Aujeszky’s disease, but failure to isolate does 
not guarantee freedom from infection. 
           
Figure n. 8: PRV: cytopathic effect on swine kidney cells 
        
Figure n. 9: PRV: Immunofluorescence and immunoperoxidase 
Identification of virus by the polymerase chain reaction 
The polymerase chain reaction (PCR) can be used to identify SHV-1 genomes in secretions or organ 
samples. Many individual laboratories have established effective protocols, but there is as yet no 
internationally agreed standardized approach. The PCR is based on the selective amplification of a 
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specific part of the genome using two primers located at each end of the selected sequence. In a 
first step, the complete DNA may be isolated using standard procedures (e.g. proteinase K 
digestion and phenol–chloroform extraction) or commercially available DNA extraction kits. Using 
cycles of DNA denaturation to give single-stranded DNA templates, hybridisation of the primers, 
and synthesis of complementary sequences using a thermostable DNA polymerase, the target 
sequence can be amplified up to 106-fold. The primers must be designed to amplify a sequence 
conserved among SHV-1 strains, for example parts of the gB or gD genes, which code for essential 
glycoproteins, have been used (Mengeling et al., 1992; Van Rijn et al., 2004; Yoon et al., 2006). A 
real-time PCR has been developed that can differentiate gE-deleted vaccine viruses from wildtype 
virus based on the specific detection of gB and gE genes (Ma et al., 2008). However, the gE specific 
real-time PCR has a lower sensitivity than the gB-specific real-time PCR. The amplified product may 
be identified from its molecular weight as determined by migration in agarose gel, with further 
confirmation where possible by Southern hybridisation using a complementary probe. Recent 
techniques involve liquid hybridisation using enzyme-labelled probes, which give a color reaction 
after incubation with the appropriate substrate. More recent techniques include the use of 
fluorescent probes linked to an exonuclease action and real-time monitoring of the evolution of 
product, enabling simultaneous amplification and confirmation of the template DNA thus 
increasing the rapidity and specificity of the PCR assays. In all cases, the main advantage of PCR, 
when compared with conventional virus isolation techniques, is its rapidity; with the most modern 
equipment, the entire process of identification and confirmation can be completed within one 
day. However, because of the nature of the test, many precautions need to be taken to avoid 
contamination of samples with extraneous DNA from previous tests or from general 
environmental contamination in the laboratory. This may limit the value of the test for many 
laboratories unless care is taken to avoid DNA carry-over contamination. The use of an internal 
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control is necessary to avoid false negative results by ensuring adequate efficiency of DNA 
extraction and confirming the absence of PCR inhibitors in each sample. In practice, different 
systems can be used for detection of endogenous or exogenous gene (Hoffman et al., 2009). 
Serological tests 
Virus neutralisation (VN) has been recognised as the reference method for serology (Moennig et 
al., 1982), but for general diagnostic purposes it has been widely replaced by the enzyme-linked 
immunosorbent assay (ELISA) because of its suitability for large-scale testing (Moennig et al., 
1982). The tests can be performed on a variety of matrices (e.g. serum, whole blood, milk, 
muscular exudates, and filter paper) but the preferred matrix is serum. A latex agglutination test 
has also been developed and can be used for screening for antibodies. It can differentiate 
between the immune response of naturally infected pigs and those that have been vaccinated 
with gE deleted vaccines (Yong et al., 2005). Kits for the test are commercially available 
(Schoenbaum et al., 1990). Serological tests are carried out only for pigs, as other animals 
(herbivores and carnivores) die too quickly to produce antibodies. In free areas where pigs are not 
vaccinated, an active epidemiological survey can be carried out using ELISA gB kits. As antibodies 
can be detected between 7 and 10 days post-infection, this serological tool can also be used in 
case of an outbreak suspicion, to confirm the infection of pigs. In area where pigs are vaccinated 
with gE deleted vaccines, the ELISA gE kits permit the differentiation between infected and 
vaccinated pigs (DIVA), but to assess the level of immunity induced by vaccination, gB ELISA kits or 
viral neutralisation should be used. Any serological technique used should be sufficiently sensitive 
to give a positive result with the OIE International Standard Reference Serum. This serum can be 
obtained from the OIE Reference Laboratory for Aujeszky’s Disease in France. For international 
trade purposes, the test should be sensitive enough to detect the standard serum diluted 1/2. To 
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authorize pig movement from an area where deleted gE vaccines are used to a free area, 
serological assays should be able to detect at least the dilution of 1/8 for ELISA gE of the OIE 
reference standard serum as prescribed by the European Commission (2008).  
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Hypothesis and objectives 
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Hypothesis 
Suid Herpesvirus (SHV-1) is the agent of Aujeszky’s disease (AD), which is spread worldwide and 
causes great economic losses in the pig industry. Pigs are the primary host of the virus but a large 
number of other species can be naturally infected. SHV-1 belongs to Herpesviridae Family, 
Alphaherpesvirinae subfamily and has a double-stranded, linear DNA genome belonging to the D 
class. The genome is characterized by two regions i.e. UL and US, with the US region flanked by the 
internal repeat sequences (IRS and TRS respectively). Out of the high number of viral proteins 
encoded by the genome, 11 are glycosylated membrane proteins involved in virus entry, egress, 
cell to cell spread and modulation of immune response. The control and eradication of AD have 
been taken into account by many countries and considerable efforts have been focussed on the 
elucidation of the epizootiology of the infection. The characterization of SHV-1 strains by means of 
identification restriction fragment length polymorphism (RFLP) analysis has greatly contributed to 
the implementation of these programs. Genomic characterization of SHV-1 has been routinely 
performed using RFLP but, recently, some studies based on the sequencing of two genes (US8 and 
UL44), encoding gE and gC proteins respectively, have been reported. In Italy, an AD national 
monitoring program has been applied since 1997. This was able to achieve a substantial reduction 
of serum prevalence in the first five years but SHV-1 is still present in the Italian swine population 
causing economic losses due to a reduction in reproductive performances and body weight. In 
many other countries of Europe AD has been eradicated in the last decade in domestic pigs but 
not in wild swine population. Despite the progress that has been made in controlling and 
eliminating SHV-1 in domestic pigs, there is mounting evidence that SHV-1 infections are more 
widespread in wild swine across the world than originally thought. The understanding of the 
extent of SHV-1 infections in these wild populations and of the threat to domestic swine is still 
fragmentary.  
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Objectives 
Study n.1 
To report the results of a Aujeszky Disease monitoring programme performed in Northern Italy 
during the period 2012-2014. This was based on control of all respiratory, nervous and 
reproductive forms, genome detection and virus isolation, serological investigations. To analyse 
the distribution of the Aujeszky Disease and evaluate the epidemiological situation in our area. 
Study n.2 
To described the isolation and the genomic characterization of PRV originated from swine in Italy 
from 1984 to 2010. To carry out the phylogenetic and molecular analysis of this strains by 
comparing gC and gE sequences with selected PRV obtained from GenBank.  
Study n.3 
To reported the results of an AD survey based on PRV genome detection in samples from dogs 
clinically suspected of AD and from wild boars collected during four consecutive hunting seasons, 
2010–2014. Dogs in which AD was clinically suspected were examined by using histopathological 
and virological methods, resulting in the isolation of 13 PRV strains from dead dogs. One strain 
isolated from a wild boar during the same period and region was also genetically characterized. 
The phylogenetic analysis was based on a partial sequence of the gC gene, and the results were 
compared with the sequences available in GenBank.  
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Study n.1 
 
Aujeszky Disease:  
serological and virological surveillance  
in Italy during 2012-2014 
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Introduction 
Pseudorabies virus (PRV) or suid herpesvirus 1 (SHV-1), a member of the Alphaherpesvirinae 
subfamily, is the causative agent of Aujeszky’s disease (AD), an economically important disease of 
pigs (Aujeszky 1902). Its host range includes a wide spectrum of mammals, although domestic and 
wild members of the Suidae family are the only hosts capable of surviving a productive infection 
and can serve as reservoirs for the virus (Pensaert and Kluge 1989). As a general pattern, wildlife 
can both maintain and spread infections to domestic species (Gortazar et al. 2007), and the wild 
boar–domestic pig interface represents an example of this interaction, as both species have 
mutual transmission risks for their parasitic and infectious diseases (Boadella et al. 2012). AD is 
such a disease, since the presence of the PRV infection in wild boar populations has been reported 
worldwide with variable prevalence rates (Ruiz-Fons et al. 2008a). Although reports of PRV 
transmission from wild boar to domestic pigs are surprisingly rare, the success of disease 
eradication programmes in the domestic species could be influenced by wildlife reservoirs (Muller 
et al. 2011). Since the early 1980s, AD has spread globally due to the appearance of more virulent 
PRV strains and to changes in swine production systems, such as increases in animal density and 
the total confinement of the animals (Muller et al. 2011). Today, the virus has spread worldwide 
and causes economic losses in the pig industry due to increased mortality rates, depending on the 
age of the host and the virulence of the virus strain involved. PRV is currently the focus of 
eradication programmes almost worldwide, which include large-scale vaccination with gE-deleted 
vaccines. This strategy, together with increased control efforts, has decreased the incidence of the 
disease in several European Union (EU) member states (Pannwitz et al. 2012). In Italy, an AD 
national monitoring programme has begun in 1997 (Decreto Ministeriale 1997); it includes the 
application of direct prophylaxis, biosecurity measures and vaccination programmes. Although AD 
has not yet been eradicated from Italian pig herds, a considerable reduction in the spread of the 
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virus has occurred. Similar to the observations in many European countries, where AD was 
eradicated in domestic pigs but not in free-living wild boar populations (Boadella et al. 2012), PRV 
has been continuously detected in wild boar in Italy (Lari et al. 2006; Montagnaro et al. 2010; 
Verin et al. 2014). Although wild boar can serve as reservoirs for PRV (Ruiz-Fons et al. 2008b), 
limited data are available on the long-term epidemiology of PRV in free-ranging populations. The 
analysis of these data may provide baseline information on PRV infection dynamics under natural 
conditions indicating those factors most influential on the spread and maintenance of the virus 
into the wild populations. Therefore, the aim of this study, through targeted surveillance, and 
using serological and molecular testing, was to describe the temporal dynamics of PRV infection 
and to define the role of wild boar population and of domestic pig farms on spread and 
maintenance of AD. 
Materials and methods 
Study Area and Sampling 
During the periods 2012–2013 and 2013–2014, wild boar tissue samples of lungs and tonsils were 
voluntarily collected by hunters in several provinces of North Italy. Tonsil samples were 
immediately processed and analyzed for the presence of PRV DNA. Clinical samples originated 
from domestic pigs were collected during the same period from routine diagnostic. Serum samples 
were obtained from routine diagnostic and from wild boars during the wildlife program.   
Laboratory Analysis 
Serological analyses were performed using an ELISA test for the detection of anti-gE antibodies 
with the Pseudorabies Virus gpI Antibody test kit (IDEXX PRV/ADV gI). The ELISA test was carried 
out according to the manufacturer’s instructions (Idexx, EK Hoofddorp, The Netherlands). Genomic 
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DNA extractions from wild boar samples were performed using an RNeasy kit (Qiagen, Hilden, 
Germany). The presence of PRV DNA was routinely determined using real-time PCR tests based on 
the specific detection of the gB and gE genes (Ma et al. 2008; Yoon et al. 2005). 
Results 
The serological tests for the detection of antibodies against the gE of Aujeszky disease virus carried 
out in 2012-2013 showed a percentage of positive samples for antibodies to gE by 7.5%, lower 
than in 2011-2012 (11.4%), confirming the downward trend shown in recent years. The serological 
testing to detect the presence of antibodies to gB performed in the same period in order to verify 
the effectiveness of vaccination, it showed a positive rate of 82.9% a slight increase over the 
previous period (82.7%). The virological analysis were conducted on the viscera of pigs through 
search of the viral genome without finding of positivity to PCR. The results of serological and 
virological pigs are summarized in Table 1. 
Table n. 1: results of serological and virological in pigs for the period 11/01/2012 - 31/10/2013 
performed by laboratories IZSLER 
 tested positive % 
gB antibodies 43235 35823 82,9 
gE antibodies 129687 9708 7,5 
virological 176 0 0 
 
Below we are also reported results of serological and virological performed for Aujeszky's disease 
in wild boar  (Table n. 2).  
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 tested positive % 
gE antibodies 5783 1127 19,5 
PCR 405 4 0.1 
 
Table n. 2: Results of serological and virological in wild boar for the period 1/11 / 2011-31 / 
10/2012 
The seropositive results mainly concerns samples of wild boars in Emilia Romagna (97.3%), while 
in Lombardy was found to be 2.7%. Virological examinations were conducted on wild boar killed in 
Lombardy during the hunting season (90%), in particularly in the province of Brescia, while the 
remaining 10% consisted of wild boars from the province of Forli. Analyses were conducted on the 
viscera of wild boar through research of the viral genome and were found four wild boars positive  
from Brescia province.  
The serological tests for the detection of antibodies against the gE of Aujeszky Disease virus 
performed in 2013-2014 in the course of activities under the control plan, revealed a percentage 
of positive samples for antibodies to gE by 9.3% . In fact the data observed in 2014 shows a slight 
increase in the percentage of positive samples that went from 7.5% in 2012-2013 to 9.3% in this 
period. This slight increase is likely due to the significant increase of serological tests (from 
129.687 in 2012-2013 to 176.956 in 2013-2014), carried out mainly in Lombardy as a result of the 
approval of the new plan to control and mainly targeting the control of farms for fattening with 
unknown health status. 
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The serological testing to detect the presence of antibodies to gB, performed in the same period, 
in order to verify the effectiveness of vaccination, showed a positivity rate of 85.5%, an increase 
over the previous period (82.9%), then sign of increased use of vaccination. 
The virological analysis were conducted on the viscera of pigs through search of the genome. The 
results of serological and virological pigs are summarized in Table 3. 
 tested positive % 
gB antibodies 42.131 36.002 85,5% 
gE antibodies 176.956 16.504 9,3% 
Virological  113 2 1,8% 
 
Table n. 3: Results of serological and virological analysis in pigs for the period 01/11/2013 - 
31/10/2014 performed by laboratories IZSLER. 
 
The following also shows the results of serological and virological analysis performed for 
Aujeszky's disease in wild boar (Table n. 4). 
 
 tested positive % 
gE antibodies 7412 1836 24,8% 
PCR 92 1 1,1% 
 
Table n. 4: Results of serological and virological analisys in wild boar for the period 1/11 /2013-31/ 
10/2014. 
 
The seropositive results mainly concerns samples of wild boars in Emilia Romagna (77.2%), while 
this in Lombardy was 22.8%. It 'been a considerable increase in the percentage of positive boars in 
Lombardy (from 2.7% in 2012-2013 to 22.8% in 2013-2014), which is mainly caused by the high 
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percentage of positive wild boars in the province of Pavia. In fact, 81.1% of positive findings in 
Lombardy is due to boars from Pavia. Figures 1 and 2 shows the percentage of positivity on 
province. 
 
 
Figure n. 1: Positive serology in wild boar in Emilia Romagna from 2010 to 2014 (data updated to 
10/31/14). 
 
 
Figure n. 2: Positive serology in wild boar in Lombardia from 2010 to 2014 (data updated to 
10/31/14). 
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Discussion 
The present long-term surveillance of AD in the wild boar and pigs of the Norther Italy showed an 
increase in seroprevalence during the years, also in the wild boars, with a higher probability of 
being seropositive in older individuals, while the presence of domestic pigs had no effect on their 
seropositivity. In particular, the total AD seroprevalence in the study area increased, showing that 
the infection could persist as an endemic disease at low prevalence values in wild boar 
populations. This was also supported by the results of the molecular analyses, where the PCR 
positive animals confirmed the presence of ADV, even with a low diffusion, inside the wild boar 
population. Domestic pigs and wild boar have a reciprocal transmission risk for their infections, 
including AD, as demonstrated by experimentally infecting domestic pigs with AD strains of wild 
boar origin, suggesting the possible AD transmission between both sides (Muller e al. 2001). 
Although the presence of ADV in wild boar already posed concerns for AD control in pigs (Corn et 
al. 2009), it has been shown that the AD prevalence in wild boar was not a significant risk factor 
for the AD prevalence in the coexisting pig farms (Ruiz-Fons et al. 2008b).  
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Study n.2 
 
 
Genomic characterization  
of pseudorabies virus strains  
isolated from swine in Italy 
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Introduction 
PRV is currently the focus of worldwide eradication programmes that have decreased the 
incidence of the disease dramatically. An AD national monitoring programme, which has been 
running in Italy since 1997, involves the application of direct prophylactic and bio-security 
measures and vaccination programmes. Vaccination includes the administration of marker 
vaccines, an inactivated form in breeder pigs and a live attenuated form in fattening pigs, which 
enabled a substantial reduction of serum prevalence in the first 5 years; however, PRV is still 
present in the Italian pig population and is causing economic loss via a reduction in reproductive 
performance and body weight. Genomic characterization of PRV has been performed routinely 
using restriction fragment length polymorphism (RFLP) analysis. Recently, however, there have 
been some studies based on sequencing genes US8 and UL44, encoding the gE and gC proteins, 
respectively (Fonseca et al., 2010; Muller et al., 2010; Serena et al., 2011). To better understand 
the epidemiology of PRV in Italy, we undertook genomic characterization of 44 PRV strains, based 
on the partial sequencing of genes US8 and UL44. These PRV strains originated from pigs isolated 
between 1984 and 2010. 
Materials and Methods 
Forty-four PRV strains isolated between 1984 and 2010 were used in this study. The 44 porcine 
isolates were from animals of different ages and from various types of farm production (farrow-to-
finish, farrow-to-weaning, fattening). The majority of these farms were examined serologically 
(sera were from the Italian compulsory plan for swine vesicular disease) to investigate the immune 
status. Swine samples were collected from farms with respiratory or reproductive problems. Data 
for materials, origin of strains and immune status of animals are given in Table 1. The porcine viral 
strains were isolated in primary cell culture and PK15. The extraction of genomic DNA was carried 
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out with one cell culture supernatant using an RNeasy kit (Qiagen, Hilden, Germany), and PCR was 
performed as described (Fonseca et al., 2010).  
Primer Sequenza primer (5’-3’)                         glicoproteina                  regione                      amplificati (bp)  
gC-2U 
gC-1L 
GTTTCCTGATTCACGCCCACGC                 gC                                    11-32                           788 
GAAGGGCTCACCGAAGAGGAC                                                        821-841 
gE-nF 
gE-nR 
CCGCGGGCCGTGTTCTTTGT                     gE                                    592-611                        493 
CGTGGCCGTTGTGGGTCAT                                                               1066-1084 
 
The PCR products were purified using a QIAquick Gel Extraction kit (Qiagen, Inc., Valencia; CA, 
USA). DNA sequencing was carried out with a Big-Dye Terminator Cycle sequencing kit (Applied 
Biosystems, Foster City, CA, USA) with the same primers as those used for amplification. 
Sequencing reactions were run by capillary electrophoresis on an automatic sequencer (ABI 3130 
Genetic Analyser; Applied Biosystems). Sequences were edited using the SeqMan program 
(DNASTAR, Madison, WI, USA), and sequence alignments were performed with the ClustalW 
method (DNASTAR); phylogenetic analysis was carried out with MEGA 5.0 (Tamura et al., 2011) 
using the neighbour-joining method with the Kimura two-parameters model; bootstrap analysis 
was carried out with 1000 replicates. The results were verified using maximum likelihood and 
maximum parsimony analysis, which showed similar topologies. The sequences were identified by 
species, state, sample number and year of isolation. The sequences of PRVs isolated from other 
countries (available through GenBank) were used for comparison with the Italian isolates. 
Deduced amino acid sequences were aligned using ClustalW, and the alignment was optimized 
manually. The sequences described here are deposited in the GenBank database.  
Results 
Phylogenetic analysis based on gE 
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Phylogenetic analysis of the US8 gene encoding the gE protein (Figure n.1) showed that sequences 
obtained from the Italian PRV isolates were divided into two large clusters, B and C (Fonseca et al., 
2010). Thirty-eight of the 44 porcine strains formed a homogeneous group located in cluster B, 
which is closely related to the 89V87 and Nova Prata reference strains from Belgium and Brazil, 
respectively. Five swine isolates (swine/It/97897/2008, swine/It/56/1987, swine/It/900/1991, 
swine/It/26940/2010 and swine/It/2106/1996) were placed in cluster C. This cluster also grouped 
the reference strains NS374 and 75V19 isolated in Belgium in the 1970s. The remaining strain, 
swine/It/3779-1/1997, showed a high degree of homology (95.7%) with the Shope strain and was 
placed into a different cluster. 
Phylogenetic analysis based on gC 
Phylogenetic analysis of the UL44 gene encoding the gC protein demonstrated wide variation 
within the Italian strains. All except two (swine/It/32501/2008 and swine/It/4742/2000) of the 
Italian porcine strains belonging to cluster B in the US8 tree were placed into the same cluster in 
the UL44 tree together with the Nova Prata reference strain. Cluster C is a homogeneous group 
that contains the strain ITA 561 (96%) isolated from a wild boar in Italy in 1993 (Capua et al., 
1997). A separate group within this cluster contained three porcine strains (swine/It/97897/2008, 
swine/It/26940/2010 and swine/It/32501/2008), that showed a high degree of homology to the 
Brazilian field strain IB341/86 (Figure n.2). The remaining porcine strains showed interesting 
features: (i) one porcine isolate (swine/It/4742/2000) located in cluster E has 100% homology to 
the NiA3 reference strain isolated from Northern Ireland; (ii) porcine strain swine/It/3779-1/1997 
in cluster D has 100% homology to the Illinois strain PRV8044; and (iii) three porcine strains 
isolated in the 1980–1990s (swine/It/56/1987, swine/It/900/1991 and swine/It/2106/1996) 
appear genetically divergent and are clustered with the Asian strains as Ea and Fa in cluster F. An 
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alignment of the deduced amino acid sequences of the gC protein showed several insertions and 
deletions. Strains belonging to cluster B exhibited deletions at positions 24 and 181 according to 
the numbering introduced by Muller et al. (2010). Finally, the three porcine strains closely related 
to the Asian strains showed interesting features: (i) an insertion of seven amino acids after 
position 72, present also in Asian strains; and (ii) a deletion of amino acids 50–52 found only in the 
Italian strains. 
Discussion 
The results of this study show that the majority of the Italian PRV strains are grouped into two 
clusters. Most (36/44) porcine PRV strains are closely related to those isolated from domestic pigs 
in Europe and America in the last 20 years and belong to cluster B in the phylogenetic trees of the 
gE and gC genes. Two other porcine strains have the gE gene belonging to cluster B, whereas the 
gC gene shows a different pattern; the gene was related to old PRV strains, one strain 
(swine/It/4742/2000) was placed into cluster C, and the other strain (swine/It/32501/2008) was 
placed into a different group, related to an NIA reference strain. The gE of the remaining six 
porcine strains, includes five isolates related to old porcine PRV strains and one (swine/It/3779-
1/1997) related to the Shope strain. The gC gene of three strains shows great variability and is 
placed into three different clusters; one into cluster D, two into cluster C and three into cluster F. 
These three strains are phylogenetically divergent, clustering with the geographically unrelated Ea 
and Fa strains from China. The divergent position might reflect an international origin for these 
strains. During the 1980s, a common procedure was to use some Chinese breeds characterized by 
a high degree of prolificacy to accelerate genetic progress (Legault, 1985), which could explain the 
origin of these strains; however, investigations based on complete sequencing of the gC and gE 
genes are in progress to investigate the genomic characteristics of these strains more fully. Two 
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molecular techniques commonly used for defining genetic relationships among pathogenic 
organisms are RFLP analysis and direct nucleotide sequencing. As described by Goldberg et al. 
(2001), both techniques indicate a lack of correlation between genetic and geographic distance 
but significant correlation between genetic and temporal distance and between genetic distance 
and host species of origin. PRV isolates representative of genomic type I are found in the United 
States and Central Europe, while isolates showing genomic type II are found predominantly in 
Central Europe and Japan. Groups III (genome type III) and IV (genome type IV) are limited strictly 
to isolates originating from Northern Europe and Thailand, respectively (Herrmann et al., 1984). 
On the basis of earlier genomic characterization based on sequencing the gC and gE genes and 
comparison with RFLP analysis, a good correlation has been shown between genotype II and 
cluster B (Schaefer et al., 2006; Fonseca et al., 2010). Furthermore, it is reported that genotype II is 
predominant in the pig population (Capua et al., 1997; Piatti et al., 2001), probably owing to its 
high virulence, and thus, pig transmissibility is higher with respect to genotype I (Glorieux et al., 
2009). Similarly, the present study shows that the most predominant group in Italy, with 36 of the 
44 PRV isolates belonging to cluster B, is referable to genotype II. Another group, cluster C, 
consists of isolates closely related to wild boar strains isolated in Europe. These strains showing a 
high degree of homology to PRV strains circulating in the 1970s and 1980s have almost 
disappeared. By contrast, strains similar to the old PRV strains are still circulating in the wild boar 
population, demonstrating that replacement with the recently discovered PRV strains has not 
taken place. The other clusters, except cluster B, were classified as genomic type I isolates. Similar 
results were reported by Muller et al. (2010), who investigated several PRV strains isolated from 
wild boar in different European countries. Amino acid analysis revealed insertions and deletions. 
All strains belonging to cluster B show deletion of the amino acids at positions 24 and 181. There is 
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an insertion of seven amino acids in all the strains in the group formed by the Italian and Asian 
strains and a deletion of three amino acids in the Italian strains.  
AD has virtually disappeared from domestic pigs in many parts of Europe, but it is still a problem in 
some countries, including Italy. The genomic characterization of SHV-1 strains originating from 
swine and other mammals might help us to better understand the population diversity and 
facilitate tracing the infection chain back to its origin. Finally, the molecular and phylogenetic 
analysis of PRV strains in this study contributes to a better understanding of the distribution of the 
virus clusters and their evolution.  
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 Year of isolation 
Sample 
n° 
Province 
of origin Type of farm 
Immune 
status Species Material 
Accession 
number gC 
Accession 
number gE 
1 
2010 
28617 RE fattening vaccinated Swine brain JQ768137 JQ619738 
2 26940 LO Farrow-to-weaning vaccinated Swine lung JQ768112 JQ619735 
3 
2008 
7145 BS fattening vaccinated Swine brain JQ768139 JQ619741 
4 29652 MN Farrow-to-weaning vaccinated Swine 
pool of 
organs* JQ768140 JQ619742 
5 32501 BS Farrow-to-weaning vaccinated Swine 
pool of 
organs JQ768110 JQ619743 
6 35155 BS Farrow-to-weaning vaccinated Swine 
pool of 
organs JQ768141 JQ619770 
7 97897 MN Farrow-to-weaning vaccinated Swine 
pool of 
organs JQ768111 JQ619771 
8 280666 BS Farrow-to-weaning vaccinated Swine 
pool of 
organs JQ768138 JQ619773 
9 2006 252504 BS fattening vaccinated Swine pool of organs JQ768126 JQ619747 
10  291822 BS fattening vaccinated Swine lung JQ768128 JQ619750 
11 
2003 
32754 CR Farrow-to-weaning vaccinated Swine foetus JQ768129 JQ619751 
12 137181 BS Farrow-to-weaning vaccinated Swine foetus JQ768123 JQ619752 
13 
2002 
285 MO fattening vaccinated Swine lung JQ768130 JQ619753 
14 1317 LO Farrow-to-finish vaccinated Swine lung JQ768131 JQ619754 
15 24939 BG Farrow-to-weaning vaccinated Swine foetus JQ768132 JQ619755 
16 47586 BS fattening vaccinated Swine lung JQ768133 JQ619756 
17 
2001 
1993 BG fattening vaccinated Swine lung JQ768134 JQ619758 
18 2945 BS fattening vaccinated Swine lung JQ768135 JQ619759 
19 4028 MO Farrow-to-finish vaccinated Swine lung JQ768136 JQ619760 
20 8225 BN fattening vaccinated Swine heart JQ768146 JQ619761 
21 15142 LO fattening vaccinated Swine foetus JQ768147 JQ619762 
22 13038 BS Farrow-to-finish vaccinated Swine foetus JQ768148 JQ619763 
23 14082 CN fattening vaccinated Swine lung JQ768124 JQ619764 
24 14096 BS fattening vaccinated Swine lung JQ768149 JQ619765 
25 14754 BG fattening vaccinated Swine pool of organs JQ768150 JQ619766 
26 
2000 
2580 MN fattening vaccinated Swine lung JQ768143 JQ619767 
27 4058 BS Farrow-to-weaning vaccinated Swine 
pool of 
organs JQ768144 JQ619768 
28 4742 MI Farrow-to-finish vaccinated Swine 
pool of 
organs JQ768113 JQ619769 
29 11719 FO fattening vaccinated Swine lung JQ768145 JQ619744 
30 12022 MO fattening vaccinated Swine lung JQ768127 JQ619748 
31 1999 12455 PG n.a. ˆ vaccinated Swine pool of organs JQ768162 JQ619734 
32 1998 361 MO fattening vaccinated Swine lung JQ768161 JQ619733 
33 1997 3779-1 MN fattening n.a. Swine pool of organs JQ768114 JQ619732 
34 1996 2106 MI Farrow-to-finish n.a. Swine liver JQ768118 JQ619737 
35 
1994 
1369 RE fattening n.a. Swine pool of organs JQ768160 JQ619731 
36 1712 MN n.a. n.a. Swine lung JQ768159 JQ619730 
37 426 PC fattening n.a. Swine pool of organs JQ768158 JQ619724 
38 182 BS Farrow-to-weaning n.a. Swine foetus JQ768157 JQ619723 
39 111 FO Farrow-to-weaning n.a. Swine foetus JQ768155 JQ619736 
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40 1991 900 FO Farrow-to-weaning n.a. Swine foetus JQ768117 JQ619727 
41 1989 36 - n.a. n.a. Swine foetus JQ768152 JQ619726 
42 1988 5658 BS n.a. n.a. Swine tonsils JQ768151 JQ619725 
43 1987 56 CR n.a. n.a. Swine brain JQ768116 JQ619721 
44 1984 54 BS n.a. n.a. Swine brain JQ768142 JQ619720 
 
Tabella n.1: Origine e descrizione dei ceppi di SHV-1 
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Figure n. 1: The phylogenetic tree based on the partial nucleotide sequence of the gE gene of 
Italian pseudorabies virus (PRV) isolates and corresponding sequences of PRV strains selected 
from GenBank. The tree was obtained by the neighbour-joining method and the Kimura two-
parameters model with 1000 bootstrap replicates. Bootstrap percentage values (>60) are 
indicated at the nodes. 
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Figure n. 2: The phylogenetic tree based on the partial nucleotide sequence of the gC gene of 
Italian pseudorabies virus (PRV) isolates and corresponding sequences of PRV strains selected 
from GenBank. 
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Introduction 
Although PRV has been eliminated in domestic pigs in many European countries, AD is being 
continuously reported in wild boar populations and in related hunting dogs (Albina et al., 2000; 
Gortazar et al., 2002; Lari et al., 2006; Leuenberger et al., 2007; Lutz et al., 2003; Muller et al., 
2010; Pannwitz et al., 2012; Roic et al., 2012; Steinrigl et al., 2012; Verin et al., 2014; Vengust et 
al., 2005; Verpoest et al., 2014). Consequently, the possible impact of wild boars on the 
application and success of AD eradication programs and the risk they pose to the PRV-free status 
should be taken into account (Boadella et al., 2012). The role of wild boars as potential reservoirs 
of PRV has become increasingly important; thus, a deeper investigation on the distribution of PRV 
strains in wild boars and their genomic characterization at a regional level became necessary. AD 
surveillance plans were carried out (a) by testing for the presence of anti-PRV antibodies in sera 
samples collected within the wildlife national monitoring program in different regions of Italy (Lari 
et al., 2006, Montagnaro et al., 2010, Verin et al., 2014) and (b) by attempting PRV genome 
detection in wild boar samples voluntary submitted by hunters of some provinces of North Italy. In 
a previous study conducted on swine strains isolated before 2010, we showed a clear distinction 
between the strains isolated from wild boars and those originated from domestic pigs. In the 
following years, we continued to monitor the epidemiology of AD in Italy to better understand the 
distribution of the virus clusters and their evolution. In this study, we report the results of an AD 
survey based on PRV genome detection in samples from dogs clinically suspected of AD from 1993 
to 2015 and from wild boars collected during four consecutive hunting seasons, 2010– 2014. Dogs 
in which AD was clinically suspected were examined by using histopathological and virological 
methods, resulting in the isolation of 22 PRV strains from dead dogs. One strain isolated from a 
wild boar during the same period and region was also genetically characterized. The phylogenetic 
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analysis was based on a partial sequence of the gC gene, and the results were compared with the 
sequences available in GenBank.  
Materials and methods  
Animals  
A total of 20 dogs of different breeds, which were conferred to IZSLER laboratories in 2004–2015, 
and two dogs collected in 1993 and 1994 were included in the study. Of the dogs, fourteen were 
hunting dogs, six were dogs living in or close to pig farms (farm dogs), and although the last two 
dog’s exposure was unknown, the dogs were unable to hunt. The origins and years of the PRV 
strain identifications are reported in Table 1. All of the hunting dogs had been used for hunting in 
the days immediately before the onset of clinical signs. Epidemiological investigations were 
conducted by the field veterinary services, and in all cases, the dogs’ owners declared that animals 
had direct contact with wild boars or had been fed PRV-infected meat and/or offal. The clinical 
signs in the dogs included neurological signs, such as tremor, trismus, spasms of the muscles of the 
larynx and pharynx, dyspnea, vomiting and pruritus. Death occurred within 24–48 h. Wild boar 
tissue samples of lungs and tonsils were voluntarily collected by hunters in several provinces of 
North Italy during the period 2011–2014. The sampling sites were divided according two different 
ecologic areas, the Alps (AP) and the Apennines (AN). A total of 176 samples originated from AP 
and 155 from AN with the following per annum distribution: 2011- 86 AP, 3 AN; 2012- 89 AP, 3 AN; 
2013- 1 AP, 99 AN; 2014- 48 AN. 2.2.  
Laboratory investigations  
Complete necropsies followed by virological examinations of selected organs were performed. The 
presence of PRV DNA in the field samples was systematically determined by real-time PCR tests 
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based on the specific detection of the gE gene as described by Yoon et al., 2005. Virus isolation 
was performed on PCR-positive samples as previously described. Histological and 
immunohistochemical investigations were completed only on fresh dog samples taken from well-
preserved carcasses. A pool of three MAbs (1F2, 2E12 and 3D5) was used. Of these, MAb 1F2 
recognized the gC protein, whereas the other two recognized the gE protein (Grieco et al., 1997). 
Phylogenetic and molecular analysis  
Partially sequencing of the gC genes was performed. Genomic DNA extraction from the cells 
culture supernatants was performed using an RNeasy kit (Qiagen, Hilden, Germany), and the PCR 
protocol described by Fonseca et al. (2010) was employed. The PCR products were purified using a 
QIAquick Gel Extraction Kit (Qiagen, Inc., Valencia; CA, USA). DNA sequencing was performed using 
a Big-Dye Terminator Cycle sequencing kit (Applied Biosystems, Foster City, CA, USA) with the 
same primers that were used for amplification. The sequencing reactions were run by capillary 
electrophoresis on an automatic sequencer (ABI 3130 Genetic Analyser; Applied Biosystems, 
Foster City, CA, USA). The sequences were edited using the SeqMan program (DNASTAR, Madison, 
USA). The sequence alignments were performed using the ClustalW W method (DNASTAR, 
Madison, USA). The best-fit model of the nucleotide substitution was determined using the 
jModelTest v.0.1.1 (Posada, 2008). All of the models were compared using two criteria; i.e., the 
Akaike’s information criterion (AIC) and the Bayesian information criterion (BIC). The preferred 
model was the HKY85 + I + G model. The phylogenetic tree was constructed with the maximum 
likelihood (ML) method within the IQ-tree software with bootstrap analyses involving 1000 
replicates (Minh et al., 2013). The topologies were verified with the neighbor-joining method and 
the Kimura two-parameter model using MEGA 5.0 (Tamura et al., 2011). The Italian isolates were 
compared with the sequences of the references and field PRV strains that originated from other 
countries and are available at GenBank. The deduced amino acid sequences were aligned using 
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ClustalW, and the alignment was manually optimized. For the molecular analyses, the presence of 
aa deletions or insertions relative to the gC prototype sequence YP068347 was analyzed. The 
predicted glycosylation sites on the gC proteins of the Italian viruses were identified with 
NetNGlyc 1.0. A threshold value of a 0.5 average potential score was set to predict the 
glycosylated sites. The sequences described in this report have been deposited in the GenBank 
database under the accession numbers reported in Table 1.  
Results  
Laboratory investigations  
During the necropsies, the external examinations of the carcasses revealed that the majority of 
animals had periorbital and facial abrasions that likely resulted from intense pruritus. Relevant 
internal gross lesions were not observed with the exception of mild to diffuse acute pulmonary 
alveolar emphysema and edema. Twenty two PRV strains were obtained from dog samples 
through inoculation onto PK-15 cells at the first passage, and the virus isolation was confirmed by 
PRV real-time PCR. Ten wild boar samples tested PCR-positive with the following spatiotemporal 
distribution: 2011- 5 AP, 2012- 2 AP, 2013- 2 AN, 2014 -1 AN. PCR-positive wild boar samples were 
also inoculated onto PK-15 cells, but the virus isolation and PCR for sequencing was attempted 
only in one case (WB-It-309516-2-2011). Immunohistochemistry performed in some dog samples 
revealed viral antigens in the cytoplasm of both neurons and glial cells within inflamed brain 
tissue.  
Phylogenetic and molecular analysis  
The phylogenetic analysis revealed that the Italian strains were divided into the following three 
clades. Clade 1 included fourteen strains from hunting dogs and one strain from a wild boar, and 
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they were closely related to another strain (ITA561) that was previously isolated from Italian wild 
boar in 1993 (Capua et al., 1997). This clade formed a separate Italian group (Italian clade 1) that 
was clearly distinguishable within Muller’s clade A, which included the PRV European feral strains. 
Clade 2 was formed by three strains that were from three farm dogs and two non-hunting dogs of 
unknown exposure; these strains were closely related to Italian clade 2, field strains that were 
isolated in 2008–2011 from pigs and other farm dogs. This group exhibited a high percentage of 
similarity (99%) to the reference strain S66 that was isolated in Sweden and a Brazilian strain 
(IB341/86) that had not previously been included elsewhere. Clade 3 included the three strains 
isolated in the nineties from farm dogs which were closely related to pig strains isolated in Europe 
and America within the last 20 years (Fig. 1). The analysis of deduced amino acid (aa) sequences 
revealed that the Italian strains showed three different patterns of aa deletions or insertions that 
corresponded to the three phylogenetic clades. Italian clade 1 was characterized by only a single 
aa deletion at position 25. Italian clade 2 carried two deletions at positions 25 and 39. Clade 3 
contained two aa deletions at positions 25 and 39 and, relative to the prototype sequence, and 
contained one insertion between positions 184 and 185 (184A). The analysis was then focused on 
the hot spot region located in the gC protein between residues 180 and 185, which showed the 
largest aa variations and were associated with changes in the hydrophobicity profile (Fonseca et 
al., 2012). Two different aa profiles were identified in the Italian strains; the first profile (VVVE) 
was related to the wild boar strains and was present in Italian clades 1 and 2. Interestingly, Italian 
clade 2 included only strains isolated recently from domestic pigs and from dogs unable to hunt 
and hence not exposed to the wild boar population. The second profile (ALDDD) was present in 
clade 3 and was closely related to the pig strains. The analysis of the predicted glycosylation sites 
in the gC protein showed a highly conserved pattern in all of the PRV strains. It was characterized 
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by three glycosylation sites at positions 40, 84 and 192 according to the prototype sequence 
YP068347 numbering (Fig. 2).  
Discussion  
Based on the gC analysis, the Italian PRV strains were primarily distributed into three different 
clusters, and this distribution revealed interesting findings. There was a clear distinction between 
both the wild boar strains (and those isolated from dogs that were used for hunting and 
subsequently traced back to wild boars) and the strains isolated from working farm dogs (and 
found to be closely related to strains in domestic pigs). The genetic results also indicated that the 
hunting dog and wild boar strains exhibited high homology to the PRV strains that were circulating 
in the 70 s and 80 s in pig farms. Indeed, these strains have nearly completely disappeared from 
commercial pig herds but are still circulating in feral pig populations and thus demonstrate that, in 
wild populations, the replacement of older strains with more recent PRV swine strains has not yet 
taken place. The Italian epidemiology was also found to be different from those of other European 
countries and was characterized by the presence of two typical Italian clades (Figure n.3). Strains 
originated from wild boars and epidemiologically related to hunting dogs belonged to clade A 
(Muller et al., 2010), although these formed a clearly distinguishable group (Italian clade 1). No 
strains included in clade B were found. These two clades, A and B, seem to overlap geographically 
in Central Europe but not in Italy, as isolates of both clades were found in German, Belgium and 
France (Muller et al., 2010; Verpoest et al., 2014). Strains related to those found in domestic pigs 
were conversely distributed in two different clades. One of these grouped strains, isolated until 
2010, were related to pig strains isolated in Europe and America within the last 20 year. Studies 
previously conducted in Italy detected a high PRV seroprevalence mainly in the in wild boar 
populations of the Apennine Mountains (Lari et al., 2006; Montagnaro et al., 2010; Verin et al., 
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2014). In contrast to this seroprevalence, PCR-positive samples were detected in a very few cases 
originating only from the Alps. PCR examination was performed on pooled wild boar tissues and in 
some cases only lung tissue was available. Similar to our results, the detection of a low number of 
PCR positive samples was previously reported (Steinrigl et al., 2012; Lutz et al., 2003) when non-
CNS tissues were analyzed. Unfortunately, several samples were not well preserved and only one 
strain could be isolated and sequenced. PCR results observed in this study were biased by 
sampling, thus likely not representative of the AD prevalence, and were used only to perform a 
better genomic characterization of PRV strains circulating in our country. All of the other isolates 
were obtained from clinically affected dogs that were divided into hunting dogs (n. 14) 
epidemiologically related to wild boars and dogs living in pig farms (n. 6) and then related to 
domestic pigs. Moreover, for two dogs, no data were available, but it were unable to hunt and 
thus not exposed to wild boars. Sequence analysis further supported these two different 
epidemiologic linkages, showing a clear relationship between hunting dogs and wild boars and a 
distinct distribution for strains related to domestic pigs. AD infections could be transmitted from 
domestic pigs to wild boars and vice versa as demonstrated by the presence of some domestic pig 
and wild boar isolates that cluster together (Muller et al., 2010; Verpoest et al., 2014). Moreover, 
the transmission between both populations was confirmed in experimental infections (Muller et 
al., 2001). Despite these considerations, the role of wild boars as AD reservoirs for domestic pigs 
has been rejected by Muller et al. (2011) because genomic analysis evidenced genomic differences 
between virus strains in the two populations. Our results are in line with this hypothesis, 
suggesting the presence in Italy of two distinct infection cycles related to wild boars and domestic 
pigs. Although the region used for sequence analysis is a small part of the complete SHV1 genome 
and deeper studies of genomic characterization should be taken into account, our results 
suggested that Italian wild boars and domestic pigs could provide two distinct ecological niches for 
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the Italian AD strains. Molecular analysis and the presence of amino acid insertions/deletions were 
consistent with the phylogenetic analysis and confirmed the presence of two Italian clades, which 
were characterized by two patterns not described in other European strains. Additionally, the 
amino acid sequence in the hot spot region is different in the two Italian clades. It has been 
hypothesized that the complete substitution (from VVVE to ALDDD), evidenced in the recent 
domestic pig strains and in our group 3, is related to changes in the hydrophilicity profile and then 
the region could be more antigenically exposed (Fonseca et al., 2012). Interestingly, Italian clade 2, 
which included recent domestic pig strains and epidemiologically related dog strains, did not show 
these substitutions and showed a profile similar to the wild boar strains. Sequencing of more 
extended parts of genome should be taken into account to better characterize these Italian 
strains. Moreover, it would be interesting to perform additional in vivo infection experiments in 
wild boars and pigs using strains belonging to the Italian clades to deeper investigate their 
pathogenesis in different hosts. Although several regions of Northern Italy have implemented AD 
eradication programs in domestic pigs, the risk of transmission from wild boars to domestic pigs 
should not be completely ruled out and may be considered a constant threat. If preventive 
measures are disregarded, transmission between wild boars and free-range pigs or outdoor pigs 
might be possible. Therefore, the epidemiology in domestic pigs and wild boars should be 
continuously monitored and assessed. 
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Year N° Sample n. Province of origin Species (attitude) –Breed Age (years) gC clade Accession 
number gC 
1993 1 3718 Piacenza Farm Dog- n.a. n.a. Clade 3 KP780805 
1994 2 736 Piacenza Farm Dog- n.a. n.a. Clade 3 KP780806 
2004 3 249465 Bologna Hunting Dog –n.a n.a. 
Italian 
Clade 1 JQ768122 
2007 4 13814 Cremona Farm Dog- n.a. n.a. Clade 3 JQ768125 
2008 5 203379 Reggio Emilia Hunting Dog –n.a. n.a. 
Italian 
Clade 1 JQ768119 
2009 6 980 Reggio Emilia Hunting Dog –n.a. n.a. 
Italian 
Clade 1 JQ768120 
2010 7 294871 Piacenza Hunting Dog –n.a. n.a. Italian Clade 1 KP862621 
 8 325409 Bologna Hunting Dog –n.a. n.a. Italian Clade 1 JQ768115 
 9 325415 Bologna Hunting Dog –n.a. n.a. Italian Clade 1 JQ768121 
 10 101452 Brescia Dog –n.a n.a. Italian Clade 2 JQ768109 
2011 
11 286509 Brescia Hunting Dog- Maremma-Hound 4 Italian Clade 1 KP862611 
12 286672 Pavia Hunting Dog - Mongrel 4 Italian Clade 1 KP862612 
13 290422 Brescia Hunting Dog- Hound 3 Italian Clade 1 KP862613 
14 309516-2 Brescia Wild Boar n.a. 
Italian 
Clade 1 KP893284 
15 310919/1 Brescia Hunting Dog-            Jura hound dog >5 
Italian 
Clade 1 KP862614 
 16 310919/2 Brescia Hunting Dog- Maremma -Hound  >5 
Italian 
Clade 1 KP862615 
2012 
17 4966 Cremona Farm Dog –n.a. n.a. Italian Clade 2 KP862616 
18 22640 Milano Farm Dog –n.a. <1 Italian Clade 2 KP862617 
19 160938 Napoli Dog – n.a. n.a. 
Italian 
Clade 2 KP862618 
2014 
20 299424 Piacenza Hunting Dog –n.a. 2 
Italian 
Clade 1 KP862619 
21 360167 Forlì Hunting Dog –n.a. n.a. Italian Clade 1 KP862620 
2015 
22 190449 Bologna Farm Dog- n.a. n.a. Italian Clade 2           - 
23 147046 Parma Hunting Dog –n.a. n.a. Italian Clade 1 - 
 
Table n. 1 – Data of the Italian PRV strains used in the study 
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Figure n. 1: Phylogenetic tree based on the partial nucleotide sequences of the gC gene (690 bp) of 
the Italian pseudorabies virus (PRV) isolates (boldface) and the corresponding sequences of the 
selected PRV strains from GenBank. The tree was obtained using the maximum likelihood method 
and the HKY85 + I + G model with 1000 bootstrap replicates. The bootstrap percentage values are 
indicated at the nodes. 
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                     25             39 
#YP068347_Prototype_sequence   MASLARAMLA LLALYAAAIA AAPSTTTALD TTPNGGGGGN SSEGELSPSP PPTPAPASPE AGAVSTPPVP PPSVSRRKPP  [ 80] 
#NIA3_glycoprotein_gIII        .......... .......... .........G .......... .......... .......... .......... ..........  [ 80] 
#WildB-It-309516-2_2011_It_cl1 .......... .......... ....-....G .......... .......... ........G. .......RA. ..........  [ 80] 
#Dog_It_22640_2012_It_cl2      .......... .......... ....-....G ........-. .......... .......... V......RA. ..........  [ 80] 
#Dog_It_3718_1993_clade_3      .......... .......... ....-....G ........-. .......... .......... .......RA. ..........  [ 80] 
 
       84 
#YP068347_Prototype_sequence   RNNNRTRVHG DKATAHGRKR IVCRERLFSA RVGDAVSFGC AVFPRAGETF EVRFYRRGRF RSPDADPEYF DEPPRPELPR  [160] 
#NIA3_glycoprotein_gIII        .......... .......... .......... .......... .......... .......... .......... ..........  [160] 
#WildB-It-309516-2_2011_It_cl1 .........S .......... .......... .......... .......... .......... .......... .....SD...  [160] 
#Dog_It_22640_2012_It_cl2      .......... .......... ....G..... .......... .......... .......... .......... ..........  [160] 
#Dog_It_3718_1993_clade_3      .......... .......... .......... .......... .......... .......... .......... ..........  [160] 
 
                                                  180   185      192  
#YP068347_Prototype_sequence   ERLLFSSANA SLAHADALAP VVVE-GERAT VANVSGEVSV RVAAADAETE GVYTWRVLSA NGT [223] 
#NIA3_glycoprotein_gIII        .......... .......... ....-..... .......... .......... .......... ... [223] 
#WildB-It-309516-2_2011_It_cl1 .......... .......... ....-.G... .......... .......... .......... ... [223] 
#Dog_It_22640_2012_It_cl2      .......... .......... ....-..... .......... .......... .......... ... [223] 
#Dog_It_3718_1993_clade_3      .......... .......... ALDDD.G... .......... .......... .......... ... [223] 
 
 
Figure n. 2: Amino acid alignment of deduced gC protein sequences from three strains 
representatives of the Italian clades 1 and 2 and group 3. The position of deletions and insertions 
are reported respect to the prototype sequence YP068347. The hot spot region is indicated by a 
box. N-glycosylation sites are shown in bold face. 
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Figure n. 3: Geographical distribution of PRV isolated   
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General conclusion 
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Pseudorabies virus (PRV) is the agent of Aujeszky’s disease (AD), a neurological porcine disorder 
that was first described over a century ago (Aujeszky, 1902). AD occurs worldwide and causes 
great economic losses in the pig industry, owing to respiratory distress, nervous system disorders, 
genital disorders and consequent high mortality rate, according to the age of the host and the 
virulence of the virus strain involved. Despite its broad host range, which includes nearly all 
mammals except higher primates and humans, members of the Suidae family (domestic pigs and 
wild boar) are the only hosts capable of surviving a productive infection and serve as a reservoir of 
the virus. PRV belongs to the Alphaherpesvirinae subfamily of the Herpesviridae family; it has a 
double-stranded, linear DNA genome of approximately 150 kb and belongs to the D class. This is 
characterized by two regions, UL and US, with the US region flanked by the internal repeat 
sequences (IRS and TRS, respectively). The viral genome encodes many proteins; 11 are 
glycosylated membrane proteins involved in virus entry, egress, cell-to-cell spread and modulation 
of immune response. The glycoprotein C is a non-essential component of the virion envelope and 
is involved in the attachment of the virion to the cell (Mettenleiter, 1999). Immunologically, gC is a 
major target for both cellular and humoral immunity in pigs (Zuckermann et al., 1990; Katayama et 
al., 1997). It is considered as the more variable part of the PRV genome owing to genetic 
alterations as a result of antibody selection. Sequence-level genetic variation in gC was reported 
by Ishikawa et al. (1996) as 2–3% among strains from diverse geographic areas. The glycoprotein E 
appears to have a prominent role in the spread of PRV within the nervous system. Deletion of the 
non-essential envelope glycoprotein E leads to a significant decrease in the virulence of some PRV 
strains. Glycoproteins E and I form a complex via a non-covalent bond that is expressed on the 
surface of PRV-infected cells (Jacobs et al., 1994). Pseudorabies virus primarily affecting pigs but 
also known to occur occasionally in cattle, sheep, goats, horses, dogs and cats. AD is a notifiable 
disease that causes substantial economic losses to the swine industry and has major economic 
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impact due to trade implications and income losses for farmers. Italian pig production is 
concentrated (over 80%) in the four Northern Italian regions of Lombardia, Emilia-Romagna, 
Piemonte and Veneto. The Lombardia region is the major producer, with 50% of the national pig 
production (Maiorano, 2009). Compared with the pig production of other countries, Italian pig 
production differs in the high live weight of pigs at slaughter; they are slaughtered at 10–12 
months of age when they reach a live weight of 150–170 kg and provide carcasses of 125–140 kg 
maintaining proper adiposity. The European general policy is to eradicate AD in order to support 
free intra-EU trade. However, eradication may take several years depending on the 
epidemiological situation in countries where the disease is endemic. In Italy, an AD national 
monitoring program was implemented in 1997. However, since 2011, with the issuing of Decree 
30/12/2010 and the latest update in 2014, the National Authority has put in place more strict 
measures to ensure a substantial reduction in virus circulation on pig farms. Thereafter, 
extraordinary regional control plans were implemented, especially in the Northern Italian regions 
with the highest concentrations of pig industry (Lombardia Region, D.d.s. 9/05/2014 n. 3822; 
Emilia Romagna Region, Delibera Giunta Regionale n. 1588–13/10/2014; Veneto Region, Delibera 
Giunta Regionale n. 2061–11/10/2012), to achieve AD eradication status and to be included in 
annex two of the EU Decision 2008/185/EC. Important tools in AD eradication plans included the 
use of DIVA gE-deleted vaccines, movement restrictions, more intensive serological testing and the 
application of stamping out or slaughter policies to remove infected animals. Only the Bolzano 
province was classified in this annex that includes member states or regions that applied disease 
controls programs and have already eradicated AD or are in an advanced stage of eradication. In 
this thesis I present three studies. The first study report the results of a Aujeszky Disease 
monitoring programme performed in Northern Italy during the period 2012-2014. This was based 
on control of all respiratory, nervous and reproductive forms, genome detection and virus 
82 
 
isolation, serological investigations. To analyse the distribution of the Aujeszky Disease and 
evaluate the epidemiological situation in the area of IZSLER. Today, the virus has spread worldwide 
and causes economic losses in the pig industry due to increased mortality rates, depending on the 
age of the host and the virulence of the virus strain involved. The serological tests for the 
detection of antibodies against the gE of Aujeszky Disease virus performed in 2013-2014 in the 
course of activities on the control plan, revealed a percentage of positive samples for antibodies to 
gE by 9.3%  with a slight increase. This increase is likely due to the significant increase of 
serological tests carried out mainly in Lombardy as a result of the approval of the new plan to 
control and mainly targeting the control of farms for fattening with unknown health status. 
The long-term surveillance of AD in the wild boar of the Norther Italy showed an increase in 
seroprevalence during the years, with a higher probability of being seropositive in older 
individuals, while the presence of domestic pigs had no effect on their seropositivity. In particular, 
the total AD seroprevalence in the study area increased, showing that the infection could persist 
as an endemic disease at low prevalence values in wild boar populations. This was also supported 
by the results of the molecular analyses, where the PCR positive animals confirmed the presence 
of ADV, even with a low diffusion, inside the wild boar population. The second study report the 
genomic characterization of PRV based on sequencing genes US8 and UL44, encoding the gE and 
gC proteins, respectively of 44 PRV strains, originated from pigs isolated between 1984 and 2010. 
The results shows that the most predominant group in Italy, with 36 of the 44 PRV isolates 
belonging to cluster B, is referable to genotype II. Another group, cluster C, consists of isolates 
closely related to wild boar strains isolated in Europe. These strains showing a high degree of 
homology to PRV strains circulating in the 1970s and 1980s have almost disappeared. By contrast, 
strains similar to the old PRV strains are still circulating in the wild boar population, demonstrating 
that replacement with the recently discovered PRV strains has not taken place. The other clusters, 
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except cluster B, were classified as genomic type I isolates. Similar results were reported by Muller 
et al. (2010), who investigated several PRV strains isolated from wild boar in different European 
countries. Finally, the third study report the results of an AD survey based on phylogenetic analysis 
was based on the gC in samples from dogs clinically suspected of AD (22 PRV strains) and from 
wild boars collected during four consecutive hunting seasons, 2010– 2014 (one strain isolated 
from a wild boar). The Italian PRV strains were primarily distributed into three different clusters, 
and this distribution revealed interesting findings. There was a clear distinction between both the 
wild boar strains (and those isolated from dogs that were used for hunting and subsequently 
traced back to wild boars) and the strains isolated from working farm dogs (and found to be 
closely related to strains in domestic pigs). The genetic results also indicated that the hunting dog 
and wild boar strains exhibited high homology to the PRV strains that were circulating in the 70 s 
and 80 s in pig farms. Indeed, these strains have nearly completely disappeared from commercial 
pig herds but are still circulating in feral pig populations and thus demonstrate that, in wild 
populations, the replacement of older strains with more recent PRV swine strains has not yet 
taken place. The Italian epidemiology was also found to be different from those of other European 
countries and was characterized by the presence of two typical Italian clades. Strains originated 
from wild boars and epidemiologically related to hunting dogs belonged to clade A (Muller et al., 
2010), although these formed a clearly distinguishable group (Italian clade 1). No strains included 
in clade B were found. These two clades, A and B, seem to overlap geographically in Central 
Europe but not in Italy, as isolates of both clades were found in German, Belgium and France. 
Strains related to those found in domestic pigs were conversely distributed in two different clades. 
One of these grouped strains, isolated until 2010, were related to pig strains isolated in Europe 
and America within the last 20 year. The present long-term surveillance may provide baseline 
information on the dynamics of AD infections under natural conditions. In addition, these results 
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together with the absence of evidence of epidemiological association of ADV between the 
domestic pig and the wild boar in the study area corroborate the hypothesis that AD maintenance 
in the wild boar population is independent of the occurrence of AD in pigs (Muller et al. 1998; 
Ruiz-Fons et al. 2008b; Pannwitz et al. 2012). Nevertheless, since spillovers cannot completely be 
ruled out and due to the fact that these results reinforce the idea that wild boar is able to maintain 
the virus at natural condition also at low density values, open-air pig systems, in particular, might 
be at risk if preventive measures are disregarded (Pannwitz et al. 2012; Ruiz-Fons et al. 2008a, b). 
These findings may be considered when implementing ADV eradication programmes in livestock, 
in particular, in areas where the wild boar population is maintained at a low density, as in the Alps. 
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